RESULT_COUNT: 483,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
ACAD,ACAD:UW,BBG000BHGMW8,Implied FXH Analyst Target Price: $74,2017-10-19 13:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x3STbBL1Cxo/implied-fxh-analyst-target-price-74-cm861822,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-18 12:02:45 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120245770.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-16 12:07:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120736314.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ACAD,ACAD:UW,BBG000BHGMW8,Valeant Reports Positive Results on Psoriasis Drug Siliq,2017-10-13 19:01:07 +0000,https://finance.yahoo.com/news/valeant-reports-positive-results-psoriasis-190107852.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced encouraging results from the long-term phase III extension study, AMAGINE-2 on psoriasis drug Siliq."
ACAD,ACAD:UW,BBG000BHGMW8,Lilly's Verzenio Gets Priority Review in First-Line Setting,2017-10-13 15:18:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tVSPlx-Kjjw/lillys-verzenio-gets-priority-review-in-first-line-setting-cm859350,Eli Lilly and Company LLY announced that the FDA has granted priority review to its new drug application NDA for Verzenio abemaciclib This drug is looking forward to get approved for the first line treatment of advanced breast cancer Markedly the NDA was based upon the positive
ACAD,ACAD:UW,BBG000BHGMW8,Lilly&apos;s Verzenio Gets Priority Review in First-Line Setting,2017-10-13 13:02:01 +0000,https://finance.yahoo.com/news/lilly-apos-verzenio-gets-priority-130201938.html?.tsrc=rss,Eli Lilly and Company (LLY) announced that the FDA has granted priority review to its new drug application for Verzenio (abemaciclib) for the first-line treatment of advanced breast cancer.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-13 12:07:27 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120727551.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ACAD,ACAD:UW,BBG000BHGMW8,Here's Why Intercept (ICPT) Stock Lost 37% So Far in 2017,2017-10-13 01:11:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UI6rrP0GYao/heres-why-intercept-icpt-stock-lost-37-so-far-in-2017-cm859143,Shares of Intercept Pharmaceuticals Inc ICPT declined 37 4 year to date against the industry s gain of 15 4 160 In particular shares have plunged 40 4 over a month due to safety issues regarding approved drug Ocaliva Per a recent news article prescriptions of the drug
ACAD,ACAD:UW,BBG000BHGMW8,Here&apos;s Why Intercept (ICPT) Stock Lost 37% So Far in 2017,2017-10-12 22:56:10 +0000,https://finance.yahoo.com/news/apos-why-intercept-icpt-stock-225610908.html?.tsrc=rss,Shares of Intercept Pharmaceuticals (ICPT) have plunged 37% in the year so far due to safety issues regarding approved drug Ocaliva.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-12 12:16:09 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120352089.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA,2017-10-11 21:12:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gjcCToBRmUk/allergans-uterine-fibroids-candidates-nda-accepted-by-fda-cm858431,Allergan plc AGN announced that the FDA has accepted the new drug application NDA for its pipeline candidate ulipristal acetate Allergan is looking to get ulipristal acetate approved for the treatment of abnormal uterine bleeding from fibroids in that organ The company expects the FDA
ACAD,ACAD:UW,BBG000BHGMW8,Allergan&apos;s Uterine Fibroids Candidate&apos;s NDA Accepted by FDA,2017-10-11 19:34:07 +0000,https://finance.yahoo.com/news/allergan-apos-uterine-fibroids-candidate-193407903.html?.tsrc=rss,"Allergan plc (AGN) announced that the FDA has accepted the new drug application (NDA) for ulipristal acetate, for the treatment of abnormal uterine bleeding in women with uterine fibroids."
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : October 11, 2017",2017-10-11 15:09:31 +0000,http://finance.yahoo.com/r/5200a5d3-106c-36de-ab13-8f8c8166550a/etfs-with-exposure-to-acadia-pharmaceuticals-inc-october-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel,2017-10-10 20:50:08 +0000,https://finance.yahoo.com/news/mallinckrodt-begin-sarcoidosis-study-acthar-205008189.html?.tsrc=rss,Mallinckrodt plc (MNK) announced that it will initiate a new phase IV study on H.P. Acthar Gel as a therapy option in patients with symptomatic sarcoidosis.
ACAD,ACAD:UW,BBG000BHGMW8,Why Should You Invest in Novo Nordisk (NVO) Stock Right Now,2017-10-10 13:34:01 +0000,https://finance.yahoo.com/news/why-invest-novo-nordisk-nvo-133401255.html?.tsrc=rss,Novo Nordisk (NVO) has a strong presence in the Diabetes care market and the current quarter has seen some events happening for the company that bode well for its growth.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-10 12:03:54 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120354601.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ACAD,ACAD:UW,BBG000BHGMW8,AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation,2017-10-09 17:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z2kXkA-lhIw/astrazenecas-tagrisso-gets-breakthrough-therapy-designation-cm857089,AstraZeneca AZN announced that the FDA has granted Breakthrough Therapy Designation BTD for Tagrisso osimertinib for the first line treatment of patients with metastatic epidermal growth factor receptor EGFR mutation positive non small cell lung cancer NSCLC Tagrisso is
ACAD,ACAD:UW,BBG000BHGMW8,Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit,2017-10-09 15:55:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bONhV_b-vSg/emergent-biosolutions-acquires-sanofis-smallpox-vaccine-unit-cm857001,Emergent BioSolutions Inc EBS announced that it completed the acquisition of FDA licensed smallpox vaccine s business of Sanofi SNY ACAM2000 160 The company paid an upfront payment of 97 5 million and 20 million in milestone payments The deal also includes a potential milestone
ACAD,ACAD:UW,BBG000BHGMW8,Roche (RHHBY) Receives FDA Approval For Cobas Zika Test,2017-10-09 14:56:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HQeuXulvTrY/roche-rhhby-receives-fda-approval-for-cobas-zika-test-cm856932,Roche Holdings AG RHHBY announced that it has obtained the FDA s approval for the cobas Zika test for use on the cobas 6800 8800 Systems The approval makes it the first commercially available test for the detection of the Zika virus RNA in human plasma intended for use in screening
ACAD,ACAD:UW,BBG000BHGMW8,Emergent BioSolutions Acquires Sanofi&apos;s Smallpox Vaccine Unit,2017-10-09 13:25:01 +0000,https://finance.yahoo.com/news/emergent-biosolutions-acquires-sanofi-apos-132501853.html?.tsrc=rss,Emergent BioSolutions (EBS) announced that it has acquired FDA-licensed smallpox vaccine&apos;s business of Sanofi (SNY) ??? ACAM2000.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-09 12:03:59 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120359130.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Pros And Cons Of All The News Out Of Acadia Pharma This Week,2017-10-06 12:40:13 +0000,https://finance.yahoo.com/news/pros-cons-news-acadia-pharma-124013196.html?.tsrc=rss,"With a balanced take on many newsworthy items regarding ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) released Wednesday, Leerink reiterated its Market Perform rating on the shares of the company. At time ..."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-06 12:04:02 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120402254.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,This Biotech Rockets — Then Dips — After FDA Breakthrough Win,2017-10-05 20:47:13 +0000,http://finance.yahoo.com/r/1796161d-cb7e-356e-bf3d-fd04a513aeaa/this-biotech-rockets-then-dips-after-fda-breakthrough-win?src=A00220&yptr=yahoo&.tsrc=rss,"Acadia briefly rallied, then dipped Thursday, after winning breakthrough approval for its dementia drug."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia's FDA Breakthrough Designation For Pimavanserin Draws Mixed Response,2017-10-05 18:20:08 +0000,https://finance.yahoo.com/news/acadias-fda-breakthrough-designation-pimavanserin-182008826.html?.tsrc=rss,ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough Designation to the company’s dementia-related psychosis drug candidate ...
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA's Antipsychotic Drug Gets Breakthrough Therapy Status,2017-10-05 17:48:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ccG5twBHj8Q/acadias-antipsychotic-drug-gets-breakthrough-therapy-status-cm855879,ACADIA Pharmaceuticals Inc ACAD announced the initiation of a phase III study HARMONY for evaluating its antipsychotic drug Nuplazid for the treatment of hallucinations and delusions associated with dementia related psychosis The FDA also granted Breakthrough Therapy Designation to
ACAD,ACAD:UW,BBG000BHGMW8,2 Stocks Move in After-Hours Trading,2017-10-05 17:47:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-QD9r8OQ94w/2-stocks-move-in-after-hours-trading-cm855917,On Wednesday U S stock market indexes closed in the green after opening lower The S amp P 500 and the Dow Jones Industrial Average recorded highs The S amp P 500 rose 0 12 points to close at 2 537 74 the Nasdaq Composite gained 0 04 to 6 534 63 and the Dow Jones increased 0 09
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA&apos;s Antipsychotic Drug Gets Breakthrough Therapy Status,2017-10-05 15:57:03 +0000,https://finance.yahoo.com/news/acadia-apos-antipsychotic-drug-gets-155703675.html?.tsrc=rss,ACADIA Pharmaceuticals&apos; (ACAD) Nuplazid granted Breakthrough Therapy Designation for dementia-related psychosis. A phase III study for the same was also initiated.
ACAD,ACAD:UW,BBG000BHGMW8,Ligand (LGND) Signs Deal to Acquire Crystal Bioscience,2017-10-05 14:52:02 +0000,https://finance.yahoo.com/news/ligand-lgnd-signs-deal-acquire-145202978.html?.tsrc=rss,"Ligand (LGND) inked a deal to acquire Crystal Bioscience, a leader in chicken-derived fully-human antibody generation, for $25 million in cash."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharma Could Rise Another 25 Percent to $50,2017-10-05 14:07:00 +0000,http://finance.yahoo.com/r/ddc31415-1a6a-358a-8ba6-e156868b022f/acadia-pharma-could-rise-another-25-percent-50?partner=YahooSA&yptr=yahoo&.tsrc=rss,An expanded clinical trial for Acadia's anti-psychotic drug Nuplazid has buoyed the company's stock.
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharma Stock Rockets On Drug Breakthrough Nod,2017-10-05 13:01:10 +0000,http://finance.yahoo.com/r/ccbab003-befc-301c-a93b-91d139ad70c2/acadia-pharma-rockets-6-after-hours-on-drug-breakthrough-nod?src=A00220&yptr=yahoo&.tsrc=rss,Acadia popped 6% late Wednesday after the FDA granted its dementia drug breakthrough designation just as the drug begins a Phase 3 trial.
ACAD,ACAD:UW,BBG000BHGMW8,"Morning Movers: Constellation Brands Jumps, Biogen Bounces, Celgene Slips",2017-10-05 12:47:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JiyjL6DFtl0/morning-movers-constellation-brands-jumps-biogen-bounces-celgene-slips-cm855551,Stocks look set for a higher open today ahead of U S jobless claims data this morning Stocks look set for a higher open today ahead of U S jobless claims data this morning Agence France Presse Getty Images Agence France Presse Getty Images S amp P 500 futures have ticked
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-10-05 12:03:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120356870.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and ImmunoGen,2017-10-05 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000921.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 5, 2017 / U.S. markets continue to reach new record highs in the fourth quarter on strong economic data. The Dow Jones Industrial Average gained 0.09 percent to close ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia shares rise on FDA dementia drug designation,2017-10-04 22:49:19 +0000,http://finance.yahoo.com/r/d1d4be77-a05f-37f6-803b-05af5a286cad/Story.aspx?guid=83D08585-1985-4140-8869-138A16F07767&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Acadia Pharmaceuticals Inc. shares rose in the extended session Wednesday after the biotech company said the Food and Drug Administration granted its dementia-related psychosis treatment a special designation ...
ACAD,ACAD:UW,BBG000BHGMW8,2 Stocks Move in After-Hours Trading,2017-10-04 22:43:43 +0000,https://finance.yahoo.com/news/2-stocks-move-hours-trading-224343761.html?.tsrc=rss,"ImmunoGen falls, Acadia rises"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase III Study of Pimavanserin in Dementia-Related Psychosis,2017-10-04 20:05:00 +0000,https://finance.yahoo.com/news/acadia-pharmaceuticals-initiates-phase-iii-200500323.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. today announced the initiation of HARMONY, a Phase III study to evaluate pimavanserin for the treatment of hallucinations and delusions associated with dementia-related psychosis, a serious medical condition for which there is no therapy approved by the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,Emergent Completes Acquisition of Anthrax Drug Raxibacumab,2017-10-04 18:32:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TtRalZISAbE/emergent-completes-acquisition-of-anthrax-drug-raxibacumab-cm855360,Emergent BioSolutions Inc EBS announced that it has closed the acquisition of anthrax monoclonal antibody raxibacumab from GlaxoSmithkline plc GSK In December 2012 160 raxibacumab was approved of by the FDA for the treatment and prophylaxis of inhalational anthrax Going forward
ACAD,ACAD:UW,BBG000BHGMW8,"Celsion's Immunotherapy Candidate Impresses, Stock Surges",2017-10-04 18:31:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y0NlXvYIEQw/celsions-immunotherapy-candidate-impresses-stock-surges-cm855349,Celsion Corporation CLSN announced results from phase Ib study OVATION evidently showing biological activity of its immunotherapy candidate GEN1 in advanced ovarian cancer patients Celsion is developing the candidate for newly diagnosed patients who will be administered in
ACAD,ACAD:UW,BBG000BHGMW8,"Noteworthy Friday Option Activity: GRA, DDD, ACAD",2017-09-29 16:34:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OKV0FRufSVI/noteworthy-friday-option-activity-gra-ddd-acad-cm853149,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Grace amp Co Symbol GRA where a total volume of 4 912 contracts has been traded thus far today a contract volume which is representative of approximately 491 200
ACAD,ACAD:UW,BBG000BHGMW8,"Allergan Authorizes New $2B Share Buyback Plan, Stock Up",2017-09-26 22:52:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DVSo_5KAkiE/allergan-authorizes-new-2b-share-buyback-plan-stock-up-cm851413,In an effort to reward shareholders the board of directors of Allergan plc AZN has sanctioned a new stock repurchase program thereby allowing the company to buy back shares worth up to 2 billion The company also reiterated its commitment to increase quarterly cash dividend annually
ACAD,ACAD:UW,BBG000BHGMW8,"Allergan Authorizes New $2B Share Buyback Plan, Stock Up",2017-09-26 21:07:09 +0000,https://finance.yahoo.com/news/allergan-authorizes-2b-share-buyback-210709706.html?.tsrc=rss,Allergan plc (AZN) sanctions a new stock repurchase program. The company also reiterates its commitment toward annual hike of quarterly cash dividend.
ACAD,ACAD:UW,BBG000BHGMW8,Biotech Acadia Could Rise 30 Percent To $50,2017-09-26 15:13:00 +0000,http://finance.yahoo.com/r/cf275bb4-9747-3aeb-9e4d-3108bcf91d99/biotech-acadia-could-rise-30-percent-50?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Strengthening fundamentals, fueled by rising revenue estimates, could propel Acadia's stock higher."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-25 12:03:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120318971.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-22 12:01:54 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120154274.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Billionaires Are Gobbling Up This Beaten-Down Biotech Stock: Should You?,2017-09-21 20:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y8F9REv79Bs/billionaires-are-gobbling-up-this-beaten-down-biotech-stock-should-you-cm849245,Julian and Felix Baker of the 15 6 billion hedge fund Baker Bros Advisors are well known for their uncanny ability to unearth hidden gems in biotech and biopharma So when I noticed that the dynamic duo purchased a noteworthy 2 million shares of the beaten down vaccine maker
ACAD,ACAD:UW,BBG000BHGMW8,Billionaires Are Gobbling Up This Beaten-Down Biotech Stock: Should You?,2017-09-21 19:00:00 +0000,http://finance.yahoo.com/r/74977cd8-bd3f-320d-83c0-bdf7bec3f356/billionaires-are-gobbling-up-this-beaten-down-biot.aspx?yptr=yahoo&.tsrc=rss,Billionaire superinvestors Felix and Julian Baker started buying shares of the beaten-down vaccine maker Novavax in the second quarter.
ACAD,ACAD:UW,BBG000BHGMW8,"Commit To Buy Acadia Pharmaceuticals At $25, Earn 8.2% Using Options",2017-09-21 17:39:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9NGXgtP98P8/commit-to-buy-acadia-pharmaceuticals-at-25-earn-82-using-options-cm849142,Investors eyeing a purchase of Acadia Pharmaceuticals Inc Symbol ACAD stock but cautious about paying the going market price of 37 17 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ACAD,ACAD:UW,BBG000BHGMW8,Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III,2017-09-21 15:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kU0-Nz28pZQ/glaxo-innovivas-triple-combo-inhaler-positive-in-phase-iii-cm848989,GlaxoSmithKline plc GSK and partner Innoviva Inc INVA announced that its once daily single inhaler triple therapy Trelegy Ellipta FF UMEC VI fluticasone furoate umeclidinium vilanterol met primary endpoint in a phase III IMPACT study showing reduction in exacerbations in patients
ACAD,ACAD:UW,BBG000BHGMW8,Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD,2017-09-19 21:38:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yfbq-he4Rvw/glaxoinnovivas-triple-combo-therapy-gets-fda-nod-for-copd-cm848042,GlaxoSmithKline plc GSK and partner Innoviva Inc INVA announced that the FDA has approved a once daily single inhaler triple combination therapy FF UMEC VI fluticasone furoate umeclidinium vilanterol as maintenance treatment for patients with chronic obstructive pulmonary
ACAD,ACAD:UW,BBG000BHGMW8,Supernus Drops SPN-810's Lower Dose Test in Phase III Trials,2017-09-19 21:37:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qB7wi7SLbMU/supernus-drops-spn-810s-lower-dose-test-in-phase-iii-trials-cm848039,Supernus Pharmaceuticals Inc s SUPN shares have dropped almost 10 after the company announced decision to stop evaluating the lower dose option 18 mg of its pipeline candidate SPN 810 in two phase III clinical trials However the company will carry on with its 36 mg dose of SPN 810
ACAD,ACAD:UW,BBG000BHGMW8,Supernus Drops SPN-810&apos;s Lower Dose Test in Phase III Trials,2017-09-19 19:12:07 +0000,https://finance.yahoo.com/news/supernus-drops-spn-810-apos-191207223.html?.tsrc=rss,"Supernus (SUPN) decides to stop evaluating the lower dose option of SPN-810 for treatment of impulsive aggression. However, the company will carry on with the study of higher dose arm or placebo."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26, 2017",2017-09-19 13:00:00 +0000,https://finance.yahoo.com/news/acadia-pharmaceuticals-present-ladenburg-thalmann-130000587.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017, at 10:00 a.m."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-19 12:03:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120356956.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA,2017-09-18 23:35:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/arkUsemfgQ0/biomarin-says-fda-not-planning-an-adcom-for-pegvaliase-bla-cm847452,BioMarin Pharmaceutical Inc BMRN announced that the FDA is currently not planning to hold an advisory committee meeting AdCom to discuss the Biologics License Application BLA for pipeline candidate pegvaliase The company is looking to get pegvaliase approved for lowering
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-18 12:02:00 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120200928.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,The Math Shows FBT Can Go To $140,2017-09-15 13:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NgWaY5HNkIk/the-math-shows-fbt-can-go-to-140-cm846165,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-15 12:01:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120157117.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,"GTx's (GTXI) Enobosarm Positive in Phase II, Shares Down",2017-09-14 23:35:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5paU_FeS8Io/gtxs-gtxi-enobosarm-positive-in-phase-ii-shares-down-cm846026,GTx Inc GTXI announced positive top line data from a phase II study evaluating lead pipeline candidate enobosarm 3 mg GTx 024 for treating postmenopausal women with stress urinary incontinence SUI Data from the study was presented at International Continence Society ICS
ACAD,ACAD:UW,BBG000BHGMW8,"GTx&apos;s (GTXI) Enobosarm Positive in Phase II, Shares Down",2017-09-14 21:50:09 +0000,https://finance.yahoo.com/news/gtx-apos-gtxi-enobosarm-positive-215009939.html?.tsrc=rss,"GTx (GTXI) posts positive data from a phase II study of enobosarm for treating women with stress urinary incontinence. However, shares dip possibly with the release falling below market estimates."
ACAD,ACAD:UW,BBG000BHGMW8,Alexion (ALXN) Reports Interim Results for Soliris Study,2017-09-14 17:40:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/clfchIE8XgQ/alexion-alxn-reports-interim-results-for-soliris-study-cm845859,Alexion Pharmaceuticals Inc ALXN announced results from an interim analysis of an ongoing phase III REGAIN study of lead drug Soliris for the treatment of patients with refractory generalized myasthenia gravis gMG who are anti acetylcholine receptor AChR antibody positive We note
ACAD,ACAD:UW,BBG000BHGMW8,Alexion (ALXN) Reports Interim Results for Soliris Study,2017-09-14 15:05:03 +0000,https://finance.yahoo.com/news/alexion-alxn-reports-interim-results-150503912.html?.tsrc=rss,Alexion (ALXN) announced results from an interim analysis of an ongoing phase III REGAIN study of Soliris. The study showed sustained treatment benefits of Soliris treatment for patients with refractory generalized myasthenia gravis.
ACAD,ACAD:UW,BBG000BHGMW8,"Perrigo's Stock Up, Starboard's CEO Calls it a Key Pick",2017-09-13 17:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WH3-7I4VfBs/perrigos-stock-up-starboards-ceo-calls-it-a-key-pick-cm845223,Perrigo Company plc s PRGO shares increased almost 5 after Jeff Smith CEO of Starboard Value a New York based investment consulting company declared that the company was a top investment option at the Delivering Alpha event hosted by CNBC Notably Perrigo is one of the world s
ACAD,ACAD:UW,BBG000BHGMW8,"Perrigo&apos;s Stock Up, Starboard&apos;s CEO Calls it a Key Pick",2017-09-13 15:29:03 +0000,https://finance.yahoo.com/news/perrigo-apos-stock-starboard-apos-152903750.html?.tsrc=rss,"Perrigo&apos;s (PRGO) shares rise with Jeff Smith, CEO of Starboard Value, certifying the company as a top investment pick, courtesy its highly potential generic business."
ACAD,ACAD:UW,BBG000BHGMW8,Marinus Stock Surges on Successful Phase II Epilepsy Study,2017-09-12 17:35:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bOYgvwkMoZc/marinus-stock-surges-on-successful-phase-ii-epilepsy-study-cm844454,Marinus Pharmaceuticals Inc MRNS announced successful completion of a phase II study assessing pipeline candidate ganaxolone for the treatment of patients with CDKL5 disorder The data supports the advancing of the candidate in a late stage study Shares rallied 33 on Monday after
ACAD,ACAD:UW,BBG000BHGMW8,Ultragenyx's Burosumab Positive in Phase II for XLH and TIO,2017-09-12 16:39:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cq6lhiUvjSg/ultragenyxs-burosumab-positive-in-phase-ii-for-xlh-and-tio-cm844428,Ultragenyx Pharmaceutical Inc RARE announced positive data from two phase II studies evaluating pipeline candidate burosumab KRN23 in children with X linked hypophosphatemia XLH and adult with tumor induced osteomalacia TIO Data from the studies were presented at the American Society
ACAD,ACAD:UW,BBG000BHGMW8,Marinus Stock Surges on Successful Phase II Epilepsy Study,2017-09-12 15:42:03 +0000,https://finance.yahoo.com/news/marinus-stock-surges-successful-phase-154203854.html?.tsrc=rss,"Marinus (MRNS) announced positive top-line data from a phase II study on its epilepsy candidate, ganaxolone, for treating CDKL5 disorder."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-09-12 12:02:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120208790.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Clovis Oncology,2017-09-11 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000000.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 11, 2017 / U.S. markets, the dollar and bond yields posted weekly losses on the combination of weather concerns and rising geopolitical tensions between the U.S. and ..."
ACAD,ACAD:UW,BBG000BHGMW8,Nuplazid for Long-Term Care: Revenue Driver for Acadia?,2017-09-08 21:06:00 +0000,http://finance.yahoo.com/r/1709617e-aae5-3126-bd4d-166b8fd04fb8/adoption-nuplazid-long-term-care-may-drive-acadia-pharmaceuticals-revenue-growth-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Acadia Pharmaceuticals (ACAD) plans to focus on long-term care (or LTC) facilities to boost Nuplazid’s adoption in the Parkinson’s disease (or PD) psychosis indication.
ACAD,ACAD:UW,BBG000BHGMW8,Nuplazid Sees Increasing Physician Intent to Prescribe in 2017,2017-09-08 19:36:06 +0000,http://finance.yahoo.com/r/2a0aa44f-12c4-3c0e-aef8-42fbff51aa6d/nuplazid-continues-witness-increasing-physician-intent-prescribe-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Acadia Pharmaceuticals' (ACAD) commercial teams have been carrying out promotional efforts to create awareness for Nuplazid among physicians with the intent to have them prescribe the drug.
ACAD,ACAD:UW,BBG000BHGMW8,Nuplazid Expected to Become a Leading Central Nervous System Drug,2017-09-08 18:01:32 +0000,http://finance.yahoo.com/r/f90371e3-a6ec-3bbd-92a2-3abf76ad2c72/nuplazid-expected-become-leading-central-nervous-system-drug-future-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On April 29, 2016, the FDA approved Acadia Pharmaceuticals’ (ACAD) Nuplazid (pimavanserin) as a first therapy for treating patients with Parkinson’s disease (or PD) psychosis."
ACAD,ACAD:UW,BBG000BHGMW8,BioMarin Presents Interim Data on BMN 250 from Phase I/II,2017-09-07 19:48:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_NUAgn4ozDo/biomarin-presents-interim-data-on-bmn-250-from-phase-iii-cm842516,BioMarin Pharmaceutical Inc BMRN announced interim data from part 2 portion of an ongoing dose escalation phase I II study on investigational enzyme replacement therapy BMN 250 currently developed for treatment of patients with Sanfilippo B syndrome or mucopolysaccharidosis IIIB MPS
ACAD,ACAD:UW,BBG000BHGMW8,BioMarin Presents Interim Data on BMN 250 from Phase I/II,2017-09-07 17:24:05 +0000,https://finance.yahoo.com/news/biomarin-presents-interim-data-bmn-172405988.html?.tsrc=rss,BioMarin&apos;s (BMRN) interim data from a current dose escalation phase I/II study on BMN 250 shows improvement signs in cognitive Development Quotient.
ACAD,ACAD:UW,BBG000BHGMW8,Merck (MRK) Opts for Buying German Immuno-Oncology Biotech,2017-09-07 16:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/47HszkA5Qwk/merck-mrk-opts-for-buying-german-immuno-oncology-biotech-cm842408,Merck MRK announced that it will acquire Germany based Rigontec a privately held immuno oncology focused biotech for an upfront cash payment of almost 137 million 115 million euros Rigontec is a leader in retinoic acid inducible gene I RIG I targeting therapeutics 160 It is a
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : September 7, 2017",2017-09-07 15:55:42 +0000,http://finance.yahoo.com/r/acdcd4b8-5865-3869-9258-1ef78321b7d6/etfs-with-exposure-to-acadia-pharmaceuticals-inc-september-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Merck (MRK) Opts for Buying German Immuno-Oncology Biotech,2017-09-07 14:32:02 +0000,https://finance.yahoo.com/news/merck-mrk-opts-buying-german-143202935.html?.tsrc=rss,"Merck (MRK) to acquire Germany-based Rigontec, a leader in retinoic acid-inducible gene I (RIG-I), a novel immuno-oncology treatment approach targeting therapeutics."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Could Report Robust Revenue Growth in 2017,2017-09-07 13:08:41 +0000,http://finance.yahoo.com/r/febc8b4d-2446-3b9a-97fd-111a7c155976/acadia-pharmaceuticals-expected-report-robust-revenue-growth-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Acadia Pharmaceuticals (ACAD) recorded net product sales close to $30.5 million based on the sell-in method of accounting."
ACAD,ACAD:UW,BBG000BHGMW8,What Analysts Recommend for Acadia Pharmaceuticals in September,2017-09-07 11:37:59 +0000,http://finance.yahoo.com/r/13d4b080-1519-37d2-8838-ba00412803dd/analysts-recommendations-acadia-pharmaceuticals-september-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the nine analysts covering Acadia Pharmaceuticals in September 2017, two rated the stock a “strong buy,” six rated it a “buy,” and one rated it a “hold.”"
ACAD,ACAD:UW,BBG000BHGMW8,"Notable ETF Inflow Detected - XBI, JUNO, EXEL, ACAD",2017-09-06 16:51:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YhXEKrFaXWo/notable-etf-inflow-detected-xbi-juno-exel-acad-cm841734,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 121 7 million dollar inflow that s a 3 0 increase week over week in outstanding
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017",2017-09-05 15:47:55 +0000,http://finance.yahoo.com/r/e9ef8745-cb19-32ad-90df-93f5bc570b63/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q2-2017-by-the-numbers-september-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis ACADIA Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of ACADIA Pharmaceuticals, Inc. – Vanda Pharmaceuticals Inc., Eli Lilly and Company, Adamas Pharmaceuticals, Inc., Johnson & Johnson, Pfizer Inc. and Bristol-Myers Squibb Company (VNDA-US, LLY-US, ADMS-US, JNJ-US, PFE-US ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,The Medicines Company's Infection Drug Vabomere Gets FDA Nod,2017-08-31 15:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9iTy3qrahf4/the-medicines-companys-infection-drug-vabomere-gets-fda-nod-cm839749,The Medicines Company MDCO announced that the FDA has granted accelerated approval to its experimental antibiotic Vabomere a combination of meropenem and vaborbactam for treating complicated urinary tract infections cUTI including the pyelonephritis The company expects to make
ACAD,ACAD:UW,BBG000BHGMW8,FDA's Refusal-to-File Letter for Inbrija Pushes Acorda Down,2017-08-30 16:52:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qPKsrxRgdQQ/fdas-refusal-to-file-letter-for-inbrija-pushes-acorda-down-cm839215,Shares of Acorda Therapeutics Inc ACOR have plunged almost 25 after the company announced that it has received a refusal to file RTF letter from the FDA in connection with the new drug application NDA for pipeline candidate Inbrija Notably Acorda is seeking approval for
ACAD,ACAD:UW,BBG000BHGMW8,FDA&apos;s Refusal-to-File Letter for Inbrija Pushes Acorda Down,2017-08-30 15:06:03 +0000,https://finance.yahoo.com/news/fda-apos-refusal-file-letter-150603343.html?.tsrc=rss,Acorda (ACOR) receives a refusal to file (RTF) letter from the FDA in connection with Inbrija&apos;s NDA.
ACAD,ACAD:UW,BBG000BHGMW8,Stocks To Watch: Acadia Pharmaceuticals Sees RS Rating Jump To 83,2017-08-30 07:00:00 +0000,http://finance.yahoo.com/r/4d591e4a-e97e-3f64-82a9-bc842b0bd4f7/stocks-to-watch-acadia-pharmaceuticals-sees-rs-rating-jump-to-83?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Acadia Pharmaceuticals shows improving technical performance.
ACAD,ACAD:UW,BBG000BHGMW8,The Medicines Co's Inclisiran Positive in Extension Study,2017-08-29 23:49:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b1S9tPbWAWI/the-medicines-cos-inclisiran-positive-in-extension-study-cm838889,The Medicines Company MDCO along with partner Alnylam Pharmaceuticals Inc ALNY announced new one year safety and efficacy data from the ongoing ORION 1 phase II study evaluating pipeline candidate Inclisiran PCSK9 Inhibitor for the treatment of hypercholesterolemia This new
ACAD,ACAD:UW,BBG000BHGMW8,Anthera's Blisibimod Positive in Phase II Extension Study,2017-08-29 16:53:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GBkXAOpCQTw/antheras-blisibimod-positive-in-phase-ii-extension-study-cm838694,Anthera Pharmaceuticals Inc ANTH announced positive top line data from the extension of a phase II BRIGHT SC study evaluating key pipeline candidate blisibimod for treatment of patients with IgA nephropathy IgAN Notably the BRIGHT SC study is randomized double blind
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-29 12:04:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120424551.html?.tsrc=rss,"Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
ACAD,ACAD:UW,BBG000BHGMW8,J&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III,2017-08-29 01:48:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/opNCnZONhMc/jjs-jnj-xareltoaspirin-regimen-positive-in-phase-iii-cm838242,Johnson amp Johnson s JNJ subsidiary Janssen announced data from a pivotal phase III study showing that its blood thinner Xarelto has significantly reduced major cardiovascular events in patients with stable coronary and peripheral artery disease CAD PAD The study is being
ACAD,ACAD:UW,BBG000BHGMW8,Minerva-J&J's Amendment of MIN-202 Contract Wins EU Approval,2017-08-29 00:49:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bc2nOtOSE2I/minerva-jjs-amendment-of-min-202-contract-wins-eu-approval-cm838224,Minerva Neurosciences Inc NERV announced that an amendment to its license agreement with Janssen Pharmaceuticals a subsidiary of Johnson amp Johnson JNJ related to co development of orexin 2 receptor antagonist MIN 202 JNJ 42827922 has been approved of in the EU Notably
ACAD,ACAD:UW,BBG000BHGMW8,Minerva-J&J&apos;s Amendment of MIN-202 Contract Wins EU Approval,2017-08-28 23:02:11 +0000,https://finance.yahoo.com/news/minerva-j-j-apos-amendment-230211613.html?.tsrc=rss,"The EU approves of Minerva&apos;s (NERV) amendment of MIN-202 license agreement with Janssen. Per the deal, Minerva will receive an upfront payment from Janssen."
ACAD,ACAD:UW,BBG000BHGMW8,"3 Stocks That Turned $8,000 Into at Least $138,000 in 5 Years",2017-08-27 17:37:00 +0000,http://finance.yahoo.com/r/ee52acec-d720-3b85-a938-179bfe15d34d/3-stocks-that-turned-8000-into-at-least-138000-in.aspx?yptr=yahoo&.tsrc=rss,"Some stocks have outperformed the market, and then there&apos;s MGP Ingredients, Acadia Pharma, and Netflix."
ACAD,ACAD:UW,BBG000BHGMW8,Ultragenyx Files BLA to FDA for Hypophosphatemia Candidate,2017-08-25 16:44:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pl660jolxgo/ultragenyx-files-bla-to-fda-for-hypophosphatemia-candidate-cm837231,Ultragenyx Pharmaceutical Inc RARE along with Japanese partner Kyowa Hakko Kirin Co Ltd announced filing of a biologics license application BLA to the FDA for its pipeline candidate burosumab KRN23 to treat patients with X linked hypophosphatemia XLH The FDA informed that a decision
ACAD,ACAD:UW,BBG000BHGMW8,"Adamas (ADMS) Dyskinesia Drug Gets FDA Approval, Stock Soars",2017-08-25 16:41:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VuuCbJmZCm4/adamas-adms-dyskinesia-drug-gets-fda-approval-stock-soars-cm837203,Adamas Pharmaceuticals Inc ADMS announced FDA approval of its Gocovri for treating dyskinesia in patients with Parkinson s disease who are on levodopa based therapy This the first drug to receive approval for this indication in the U S The approved dosage for Gocovri extended release
ACAD,ACAD:UW,BBG000BHGMW8,"Adamas (ADMS) Dyskinesia Drug Gets FDA Approval, Stock Soars",2017-08-25 14:45:02 +0000,https://finance.yahoo.com/news/adamas-adms-dyskinesia-drug-gets-144502091.html?.tsrc=rss,Adamas Pharmaceuticals&apos; (ADMS) Gocovri was approved by the FDA for treating dyskinesia in patients with Parkinson&apos;s disease. This led to an upside in shares.
ACAD,ACAD:UW,BBG000BHGMW8,Ultragenyx Files BLA to FDA for Hypophosphatemia Candidate,2017-08-25 14:23:02 +0000,https://finance.yahoo.com/news/ultragenyx-files-bla-fda-hypophosphatemia-142302575.html?.tsrc=rss,Ultragenyx (RARE) forwards a BLA to the FDA for burosumab with a view to treat patients with X-linked hypophosphatemia (XLH). The decision on acceptance will be known within a couple of months.
ACAD,ACAD:UW,BBG000BHGMW8,Kite Pharma at New 52-Week High: What's Driving the Stock?,2017-08-24 20:38:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5E3sgvPjfng/kite-pharma-at-new-52-week-high-whats-driving-the-stock-cm836783,Kite Pharma Inc s KITE shares hit a new 52 week high of 143 00 on Thursday before eventually closing at 138 17 Shares of the company have risen sharply so far this year as its CAR T therapy axicabtagene ciloleucel previously KTE C19 is nearing an FDA approval In fact Kite Pharma
ACAD,ACAD:UW,BBG000BHGMW8,Kite Pharma at New 52-Week High: What&apos;s Driving the Stock?,2017-08-24 18:34:06 +0000,https://finance.yahoo.com/news/kite-pharma-52-week-high-183406866.html?.tsrc=rss,Kite Pharma (KITE) shares hit a new 52-week high as the company&apos;s CAR-T therapy with axicabtagene ciloleucel nears an FDA nod. It has also filed regulatory application for the candidate in the EU.
ACAD,ACAD:UW,BBG000BHGMW8,Ultragenyx (RARE) Posts Disappointing Phase III Ace-ER Data,2017-08-23 22:38:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q8SuS9Vcn5M/ultragenyx-rare-posts-disappointing-phase-iii-ace-er-data-cm836242,Ultragenyx Pharmaceutical Inc RARE announced discouraging top line data from a phase III study evaluating its investigational Ace ER aceneuramic acid extended release on patients with GNE Myopathy GNEM a progressive muscle wasting disorder As a result the company plans to discontinue
ACAD,ACAD:UW,BBG000BHGMW8,Ultragenyx (RARE) Posts Disappointing Phase III Ace-ER Data,2017-08-23 20:06:08 +0000,https://finance.yahoo.com/news/ultragenyx-rare-posts-disappointing-phase-200608109.html?.tsrc=rss,Ultragenyx (RARE) plans to discontinue further clinical development of Ace-ER after posting discouraging data from a phase III study that evaluated the candidate on patients with GNE Myopathy.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-22 12:01:58 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120158067.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-21 12:04:52 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120452538.html?.tsrc=rss,"Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
ACAD,ACAD:UW,BBG000BHGMW8,Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer,2017-08-18 16:40:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0PQunh2l3n4/jazz-pharmaceuticals-arm-announces-500m-senior-notes-offer-cm833989,Jazz Pharmaceuticals Public Limited Company JAZZ announced that its wholly owned subsidiary Jazz Investments I Limited intends to offer exchangeable Senior Notes due 2024 for an aggregate principal amount of 500 million in a private offering to qualified institutional buyers Notably
ACAD,ACAD:UW,BBG000BHGMW8,Jazz Pharmaceuticals Arm Announces $500M Senior Notes Offer,2017-08-18 14:28:02 +0000,https://finance.yahoo.com/news/jazz-pharmaceuticals-arm-announces-500m-142802537.html?.tsrc=rss,Jazz Pharmaceuticals (JAZZ) announces private offering of exchangeable senior notes to qualified institutional buyers to raise proceeds and repay debt.
ACAD,ACAD:UW,BBG000BHGMW8,FDA Accepts Portola's (PTLA) BLA Resubmission for AndexXa,2017-08-17 16:39:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sIIqu04cmSo/fda-accepts-portolas-ptla-bla-resubmission-for-andexxa-cm833384,Portola Pharmaceuticals Inc PTLA recently announced that the FDA has accepted its resubmitted biologics license application BLA for the reversal agent for Factor Xa inhibitors AndexXa Andexanet Alfa A decision from the U S regulatory body is expected on Feb 2 2018 AndexXa has
ACAD,ACAD:UW,BBG000BHGMW8,FDA Accepts Portola&apos;s (PTLA) BLA Resubmission for AndexXa,2017-08-17 14:22:02 +0000,https://finance.yahoo.com/news/fda-accepts-portola-apos-ptla-142202165.html?.tsrc=rss,FDA acknowledges Portola&apos;s (PTLA) resubmitted BLA for AndexXa to raise hopes for an urgent need of antidotes for Factor Xa inhibitors in the market.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-17 12:02:20 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120220656.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,"What You See, and What You Get: The Neurology of Perception",2017-08-16 00:35:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pvFLqj7qJNY/what-you-see-and-what-you-get-the-neurology-of-perception-cm832527,1 00 Neuroscience The 4 Theaters Of The Brain 5 00 Investors Train Their Brains to Trade Assumption and Perception 10 00 Neurology Is The New Oncology The Boom In Brain Sciences 14 00 Biotech Companies With Breakthrough
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 8-Aug-17 9:00pm GMT,2017-08-14 18:30:54 +0000,https://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-092019380.html?.tsrc=rss,Q2 2017 ACADIA Pharmaceuticals Inc Earnings Call
ACAD,ACAD:UW,BBG000BHGMW8,"Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern",2017-08-14 16:38:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/orPwOHpb1Jk/gerons-gern-imetelstat-progressing-well-setbacks-concern-cm831752,We issued an updated research report on Menlo Park CA based Geron Corporation GERN on Aug 11 Geron is developing anti cancer therapies based on telomerase inhibitors The company currently has one candidate in its pipeline imetelstat It is being developed for the treatment of
ACAD,ACAD:UW,BBG000BHGMW8,Analysts Forecast 10% Gains Ahead For VXF,2017-08-14 14:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4aRkhHiYUKg/analysts-forecast-10-gains-ahead-for-vxf-cm831571,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,"Geron&apos;s (GERN) Imetelstat Progressing Well, Setbacks Concern",2017-08-14 14:37:02 +0000,https://finance.yahoo.com/news/geron-apos-gern-imetelstat-progressing-143702523.html?.tsrc=rss,"Geron Corporation&apos;s (GERN) telomerase inhibitor, imetelstat, is being evaluated in two late stage studies. The candidate is progressing well in the Janssen sponsored studies."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-12 12:04:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120342023.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-11 12:03:41 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120341947.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Today's Research Reports on Stocks to Watch: Achillion Pharmaceuticals and ACADIA Pharmaceuticals,2017-08-10 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000160.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 10, 2017 / It wasn't Achillion's financial results for the second quarter that had traders jumping on Wednesday, but an update on the company's ACH-4471 trial. ACH-4471, ..."
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-10 12:04:53 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120453108.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,"Gainers & Losers Of Aug.9: NTRA, ACHN, OMER, SGRY, PGNX...",2017-08-09 23:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I1lXQLvxbp8/gainers--losers-of-aug9-ntra-achn-omer-sgry-pgnx-20170809-01768,"Gainers & Losers Of Aug.9: NTRA, ACHN, OMER, SGRY, PGNX..."
ACAD,ACAD:UW,BBG000BHGMW8,Here's Why Acadia Pharmaceuticals Inc. Is Soaring Today,2017-08-09 19:37:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dtxAMbN1tGI/heres-why-acadia-pharmaceuticals-inc-is-soaring-today-cm829751,What happened In response to Acadia Pharmaceuticals NASDAQ ACAD reporting blow out earnings and sharing upbeat guidance shares of the commercial stage biopharma which focuses on diseases of the central nervous system were trading 13 9 higher as of 1 35 p m EDT on
ACAD,ACAD:UW,BBG000BHGMW8,'Longing' for Acadia Pharmaceuticals? Here's How to Play It,2017-08-09 19:33:00 +0000,http://finance.yahoo.com/r/87794fc3-46a9-3703-a79f-69dfc181d2c5/longing-acadia-pharmaceuticals-heres-how-play-it?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,ACAD looks strong enough for a rally at least to the upper $30s.
ACAD,ACAD:UW,BBG000BHGMW8,Here&apos;s Why Acadia Pharmaceuticals Inc. Is Soaring Today,2017-08-09 17:43:00 +0000,http://finance.yahoo.com/r/b7711dbb-376e-3274-b62e-bcaa58f5e5a1/heres-why-acadia-pharmaceuticals-inc-is-soaring-to.aspx?yptr=yahoo&.tsrc=rss,Shares popped after the company reported better-than-expected second quarter results and issued bullish full-year guidance.
ACAD,ACAD:UW,BBG000BHGMW8,"Acadia Shares Up Big On Strong Sales, Increased Confidence",2017-08-09 16:24:04 +0000,https://finance.yahoo.com/news/acadia-shares-big-strong-sales-162404439.html?.tsrc=rss,ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) shares hit a four-month high on Wednesday following the release of strong sales by the company. HC Wainwright said underlying marketing dynamics give them confidence ...
ACAD,ACAD:UW,BBG000BHGMW8,Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports,2017-08-09 14:25:02 +0000,https://finance.yahoo.com/news/why-acadia-pharma-one-wednesday-142502343.html?.tsrc=rss,Acadia Pharmaceuticals reported its second-quarter financial results after the markets closed on Tuesday.
ACAD,ACAD:UW,BBG000BHGMW8,See what the IHS Markit Score report has to say about ACADIA Pharmaceuticals Inc.,2017-08-09 12:04:53 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120453538.html?.tsrc=rss,ACADIA Pharmaceuticals Inc NASDAQ/NGS:ACAD
ACAD,ACAD:UW,BBG000BHGMW8,Biotech Acadia Sends a Loud Message to the Market,2017-08-09 10:00:00 +0000,http://finance.yahoo.com/r/5e7d143a-2c54-380a-b0ea-f7772d564253/biotech-acadia-sends-loud-message-market?partner=YahooSA&yptr=yahoo&.tsrc=rss,Acadia just sent a loud message to the market that revenues are tracking ahead of expectations.
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc. (ACAD) Has Jumped To A 3-Month High On Q2 Results,2017-08-09 09:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eVldSK24uPw/acadia-pharmaceuticals-inc-acad-has-jumped-to-a-3month-high-on-q2-results-20170809-00916,ACADIA Pharmaceuticals Inc. (ACAD) Has Jumped To A 3-Month High On Q2 Results
ACAD,ACAD:UW,BBG000BHGMW8,"ACHN Soars On PNH Data, ACAD Abuzz, ALDR On Track, Zealand To Debut On Nasdaq",2017-08-09 04:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o-uxt9xO-Eo/achn-soars-on-pnh-data-acad-abuzz-aldr-on-track-zealand-to-debut-on-nasdaq-20170809-00162,"ACHN Soars On PNH Data, ACAD Abuzz, ALDR On Track, Zealand To Debut On Nasdaq"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 2Q loss,2017-08-09 03:54:32 +0000,https://finance.yahoo.com/news/acadia-reports-2q-loss-200924618.html?.tsrc=rss,The San Diego-based company said it had a loss of 55 cents per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for ...
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 2Q loss,2017-08-08 20:09:24 +0000,https://finance.yahoo.com/news/acadia-reports-2q-loss-200924940.html?.tsrc=rss,The San Diego-based company said it had a loss of 55 cents per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for ...
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Reports Second Quarter 2017 Financial Results,2017-08-08 20:05:00 +0000,https://finance.yahoo.com/news/acadia-pharmaceuticals-reports-second-quarter-200500777.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its unaudited financial results for the second quarter ended June 30, 2017."
ACAD,ACAD:UW,BBG000BHGMW8,Investor Network: ACADIA Pharmaceuticals Inc. to Host Earnings Call,2017-08-08 17:00:00 +0000,https://finance.yahoo.com/news/investor-network-acadia-pharmaceuticals-inc-170000082.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 5:00 ..."
ACAD,ACAD:UW,BBG000BHGMW8,"Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More",2017-08-07 16:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ma9p-F1dfxo/drug-stocks-q2-earnings-roster-for-aug-8-acad-jazz-more-cm828152,The second quarter 2017 earnings season is nearing its last leg and the picture so far appears to be quite encouraging 160 After a few turbulent quarters earnings for the second quarter of 2017 showed solid strength As of Aug 4 approximately 420 S amp P 500 companies or 86 1 of the index
ACAD,ACAD:UW,BBG000BHGMW8,"Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More",2017-08-07 14:32:02 +0000,https://finance.yahoo.com/news/drug-stocks-q2-earnings-roster-143202883.html?.tsrc=rss,A look at the pharma/biotech companies that are set to report second-quarter results on Aug 8.
ACAD,ACAD:UW,BBG000BHGMW8,Will ACADIA (ACAD) Pull Off a Surprise this Earnings Season?,2017-08-02 14:59:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Z2ksbbbCx4/will-acadia-acad-pull-off-a-surprise-this-earnings-season-cm825687,ACADIA Pharmaceuticals Inc ACAD is scheduled to report second quarter 2017 results on Aug 8 after the closing bell The company s track record has been dismal Evidently ACADIA missed estimates in two of the trailing four quarters beat it once and matched the same in the remaining
ACAD,ACAD:UW,BBG000BHGMW8,Will ACADIA (ACAD) Pull Off a Surprise this Earnings Season?,2017-08-02 12:49:12 +0000,https://finance.yahoo.com/news/acadia-acad-pull-off-surprise-124912097.html?.tsrc=rss,"ACADIA Pharmaceuticals&apos; (ACAD) Nuplazid is expected to maintain the growth trend, established since its launch, in the second quarter."
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : August 1, 2017",2017-08-01 20:07:26 +0000,http://finance.yahoo.com/r/65f4c76d-1f0e-3b62-af74-da45fbdb986c/etfs-with-exposure-to-acadia-pharmaceuticals-inc-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 8, 2017",2017-08-01 13:00:00 +0000,https://finance.yahoo.com/news/acadia-pharmaceuticals-announce-second-quarter-130000575.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the second quarter ended June 30, 2017 on Tuesday, August 8, 2017, after the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Named to Forbes Magazine’s List of World’s Most Innovative Growth Companies,2017-07-25 13:00:00 +0000,https://finance.yahoo.com/news/acadia-pharmaceuticals-named-forbes-magazine-130000191.html?.tsrc=rss,ACADIA Pharmaceuticals Inc. today announced that it has been ranked 11th on Forbes Magazine’s 2017 list of the World’s Most Innovative Growth Companies. ACADIA is a biopharmaceutical company dedicated to developing and delivering innovative medicines to address unmet medical needs in central nervous system disorders.
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : July 21, 2017",2017-07-21 17:44:23 +0000,http://finance.yahoo.com/r/4b2801e7-ca80-3e47-a5ae-b31f965000e3/etfs-with-exposure-to-acadia-pharmaceuticals-inc-july-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods,2017-07-21 17:15:00 +0000,http://finance.yahoo.com/r/7d0c7a23-fc9a-31ef-962e-9fb56ff24aab/jana-partners-to-put-whole-foods-amazon-deal-windfall-to-use.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here are the activist investor's next potential targets.
ACAD,ACAD:UW,BBG000BHGMW8,These 2 Companies Have No Competition,2017-07-18 14:05:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GhluMCgH55I/these-2-companies-have-no-competition-cm817340,Warren Buffett has long championed the idea of investing in companies with durable competitive advantages He believes that a business with true moat can more easily defend its market share from competitors and generate strong returns for shareholders But if investing a company with
ACAD,ACAD:UW,BBG000BHGMW8,These 2 Companies Have No Competition,2017-07-18 12:16:00 +0000,http://finance.yahoo.com/r/e9141cff-4945-383b-858e-083f47bdd795/these-2-companies-have-no-competition.aspx?yptr=yahoo&.tsrc=rss,"Novocure and Acadia Pharmaceuticals have their niches all to themselves, and no rivals on the horizon -- a formula for profits and growth that makes their shares well worth considering."
ACAD,ACAD:UW,BBG000BHGMW8,Today's Research Reports on Stocks to Watch: ACADIA Pharmaceuticals Inc. and Mylan N.V.,2017-07-13 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000846.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 13, 2017 / U.S. markets rose Wednesday as investors reacted positively to Federal Reserve Chairwoman Janet Yellen's congressional testimony. The Dow Jones Industrial Average ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : July 12, 2017",2017-07-12 19:07:32 +0000,http://finance.yahoo.com/r/b7e71935-98ea-39f8-965b-b28ebac0077b/acadia-pharmaceuticals-inc-value-analysis-nasdaqacad-july-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ACADIA Pharmaceuticals, Inc. a score of 28. Our analysis is based on comparing ACADIA Pharmaceuticals, Inc. with the following peers – Vanda Pharmaceuticals Inc., Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, Catalyst Biosciences, Inc., Bristol-Myers Squibb Company and Adamas Pharmaceuticals, Inc. (VNDA-US, PFE-US, JNJ-US, LLY-US, ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,The Math Shows BBH Can Go To $140,2017-07-12 14:44:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j6F-eEB6c8c/the-math-shows-bbh-can-go-to-140-cm814932,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : July 11, 2017",2017-07-11 13:19:33 +0000,http://finance.yahoo.com/r/84b09ded-0d7d-3ba6-bea6-febdde2c3fc7/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-july-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ACADIA Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : July 10, 2017",2017-07-10 17:49:46 +0000,http://finance.yahoo.com/r/b73790c9-d1de-3743-a3ef-3ab8a8af2f80/etfs-with-exposure-to-acadia-pharmaceuticals-inc-july-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : June 27, 2017",2017-06-27 18:47:37 +0000,http://finance.yahoo.com/r/46609e89-a8cd-3a12-864b-16862503c475/etfs-with-exposure-to-acadia-pharmaceuticals-inc-june-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : June 27, 2017",2017-06-27 12:54:49 +0000,http://finance.yahoo.com/r/5957faac-4e01-3f71-82d3-aad06505e1ec/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-june-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ACADIA Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Minerva On Track to Initiate Phase III Schizophrenia Study,2017-06-26 15:53:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6SwTNqupRNs/minerva-on-track-to-initiate-phase-iii-schizophrenia-study-cm808096,Minerva Neurosciences Inc NERV announced that it is on track to begin phase III studies on its key schizophrenia pipeline candidate MIN 101 in the second half of this year as planned The company said that it has completed a bridging study to select a new and safer formulation of MIN
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotech Stocks for Enterprising Investors,2017-06-23 13:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WCDy7ozik4/3-biotech-stocks-for-enterprising-investors-cm807280,Biotech stocks are a natural area of exploration for aggressive investors with high expectations for their stocks After all this high growth industry is chock full of novel growth platforms some of which can be challenging to understand at times With this theme in mind we
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotech Stocks for Enterprising Investors,2017-06-23 12:04:00 +0000,http://finance.yahoo.com/r/092f4252-d499-3d88-8cd4-8fc44ee3ed92/3-biotech-stocks-for-enterprising-investors.aspx?yptr=yahoo&.tsrc=rss,"Kite Pharma, Celgene, and Acadia Pharmaceuticals are three biotech stocks that should be on enterprising investors&apos; radars. Here&apos;s why."
ACAD,ACAD:UW,BBG000BHGMW8,3 Value Stocks You Haven't Thought Of,2017-06-19 20:20:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_8YUU848dPw/3-value-stocks-you-havent-thought-of-cm805313,You can always find some value stocks in every industry regardless of how high the markets are That s because the markets aren t always rational which means some fundamentally strong companies with growth catalysts intact might find themselves at the receiving end for no
ACAD,ACAD:UW,BBG000BHGMW8,3 Value Stocks You Haven&apos;t Thought Of,2017-06-19 18:33:00 +0000,http://finance.yahoo.com/r/28511c42-2c7b-3ae4-8d3e-54207ad349d0/3-value-stocks-you-havent-thought-of.aspx?yptr=yahoo&.tsrc=rss,"Thinking value stocks? Pay attention to Baidu, Acadia Pharmaceuticals, and Dycom Industries."
ACAD,ACAD:UW,BBG000BHGMW8,"Baker Bros. Advisors Lp Buys Incyte Corp, AveXis Inc, La Jolla Pharmaceutical Co, Sells AbbVie ...",2017-06-17 19:18:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nJ8GTrEIjno/baker-bros-advisors-lp-buys-incyte-corp-avexis-inc-la-jolla-pharmaceutical-co-sells-abbvie-cm804758,Baker Bros Advisors Lp New Purchases ANAB JNCE TNXP BPMX WINT Added Positions INCY AVXS LJPC ASND AQXP HRTX BCRX CBAY DERM SGMO Reduced Positions ARRY EXEL ZGNX VSAR AGLE CRBP JUNO NTRA PRTO Sold Out ABBV DSCI ADHD ENTA
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : June 16, 2017",2017-06-16 19:19:12 +0000,http://finance.yahoo.com/r/151dd4f7-1c08-3da5-8ed7-6bad8ba92133/etfs-with-exposure-to-acadia-pharmaceuticals-inc-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Sum Up The Pieces: BBH Could Be Worth $138,2017-06-06 15:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eYDDLOKk1zs/sum-up-the-pieces-bbh-could-be-worth-138-cm799307,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : June 5, 2017",2017-06-05 17:58:28 +0000,http://finance.yahoo.com/r/b9432018-5998-347e-82c0-eb80b4d8b0b9/etfs-with-exposure-to-acadia-pharmaceuticals-inc-june-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017",2017-06-02 13:59:03 +0000,http://finance.yahoo.com/r/cf0c245c-c91f-3658-9791-0683d38869bb/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q1-2017-by-the-numbers-june-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis ACADIA Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of ACADIA Pharmaceuticals, Inc. – Vanda Pharmaceuticals Inc., Pfizer Inc., Johnson & Johnson, Eli Lilly and Company, Catalyst Biosciences, Inc., Bristol-Myers Squibb Company and Adamas Pharmaceuticals, Inc. (VNDA-US, PFE-US, ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 9-May-17 9:00pm GMT,2017-05-12 01:20:29 +0000,http://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-021133045.html?.tsrc=rss,Q1 2017 ACADIA Pharmaceuticals Inc Earnings Call
ACAD,ACAD:UW,BBG000BHGMW8,Oversold Conditions For Acadia Pharmaceuticals (ACAD),2017-05-10 18:02:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QlDG7YSv1ds/oversold-conditions-for-acadia-pharmaceuticals-acad-cm787347,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ACAD,ACAD:UW,BBG000BHGMW8,"Wednesday's ETF Movers: GDXJ, BBH",2017-05-10 18:01:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ecXiOuEzFC0/wednesdays-etf-movers-gdxj-bbh-cm787337,In trading on Wednesday the Junior Gold Miners ETF GDXJ is outperforming other ETFs up about 2 9 on the day Components of that ETF showing particular strength include shares of Iamgold IAG up about 9 9 and shares of First Mining Finance FF CA up about 9 8 on the day
ACAD,ACAD:UW,BBG000BHGMW8,Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher,2017-05-10 17:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6v_hCvbD4U/mid-day-market-update-crude-oil-down-3-proteon-therapeutics-shares-spike-higher-cm787357,Midway through trading Wednesday the Dow traded down 0 08 percent to 20 959 85 while the NASDAQ declined 0 12 percent to 6 113 15 The S amp P also rose gaining 0 02 percent to 2 397 31 Leading and Lagging Sectors Energy sector was the top gainer in the US market on Wednesday
ACAD,ACAD:UW,BBG000BHGMW8,Is This Why Acadia Pharmaceuticals Inc. Is Plunging Today?,2017-05-10 17:03:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5ZxWvbhBmkY/is-this-why-acadia-pharmaceuticals-inc-is-plunging-today-cm787303,What happened In response to the company reporting first quarter earnings shares of Acadia Pharmaceuticals NASDAQ ACAD 160 a commercial stage biopharma focused on diseases 160 of the central nervous system fell by 11 as of 11 00 a m EDT So what Here s
ACAD,ACAD:UW,BBG000BHGMW8,The Acadia Sell-off Is Overdone,2017-05-10 16:25:00 +0000,http://finance.yahoo.com/r/3bad4ee8-e67e-3bf5-9e4a-2b1078f0c2a4/acadia-selloff-overdone?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Shares of Acadia Pharmaceuticals are tanking this morning, but that could be a great buying opportunity."
ACAD,ACAD:UW,BBG000BHGMW8,Is This Why Acadia Pharmaceuticals Inc. Is Plunging Today?,2017-05-10 15:39:00 +0000,http://finance.yahoo.com/r/42c4a401-1640-35c9-ac4d-ee469c263474/is-this-why-acadia-pharmaceuticals-inc-is-plunging.aspx?yptr=yahoo&.tsrc=rss,"Despite upbeat first-quarter earnings results, shares of the commercial-stage biopharma fell by double digits."
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Roughly Flat After Seeing Early Weakness - U.S. Commentary,2017-05-10 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zA3EBeOulp0/stocks-roughly-flat-after-seeing-early-weakness--us-commentary-20170510-01175,Stocks Roughly Flat After Seeing Early Weakness - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Political Uncertainty Leads To Modest Weakness On Wall Street - U.S. Commentary,2017-05-10 10:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tvjX3sDdB_4/political-uncertainty-leads-to-modest-weakness-on-wall-street--us-commentary-20170510-01074,Political Uncertainty Leads To Modest Weakness On Wall Street - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 1Q loss,2017-05-09 22:00:47 +0000,http://finance.yahoo.com/news/acadia-reports-1q-loss-220047736.html?.tsrc=rss,The San Diego-based company said it had a loss of 72 cents per share. The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for ...
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Reports First Quarter 2017 Financial Results,2017-05-09 20:05:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-reports-first-quarter-200500556.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2017."
ACAD,ACAD:UW,BBG000BHGMW8,Investor Network: ACADIA Pharmaceuticals Inc. to Host Earnings Call,2017-05-09 17:30:00 +0000,http://finance.yahoo.com/news/investor-network-acadia-pharmaceuticals-inc-173000626.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 9, 2017 / ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 5:00 PM Eastern Time. ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017",2017-05-08 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-bank-america-130000650.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Bank of America Merrill Lynch 2017 Healthcare Conference on Tuesday, May 16, 2017, at 10:00 a.m."
ACAD,ACAD:UW,BBG000BHGMW8,What to do when your biotechnology stock gets hit by takeover rumors,2017-05-04 16:31:18 +0000,http://finance.yahoo.com/r/56ba24cf-8e51-3469-94d1-160752331ef1/Story.aspx?guid=0CB86EB2-301A-11E7-98BF-F86B6FF9DD6C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Also, 10 biotech companies that might be targets. By Michael Brush."
ACAD,ACAD:UW,BBG000BHGMW8,Analysts Forecast 12% Upside For BBH,2017-05-04 14:13:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W6-sOyMFAsM/analysts-forecast-12-upside-for-bbh-cm784035,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,What's in the Cards for ACADIA (ACAD) this Earnings Season?,2017-05-02 14:30:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vtZDwwfOXYo/whats-in-the-cards-for-acadia-acad-this-earnings-season-cm782692,ACADIA Pharmaceuticals Inc ACAD is expected to report first quarter 2017 results on May 4 The company s track record has been dismal Evidently ACADIA missed estimates in three of the trailing four quarters bringing the average negative surprise to 13 67 In the last reported
ACAD,ACAD:UW,BBG000BHGMW8,What&apos;s in the Cards for ACADIA (ACAD) this Earnings Season?,2017-05-02 13:11:01 +0000,http://finance.yahoo.com/news/apos-cards-acadia-acad-earnings-131101670.html?.tsrc=rss,ACADIA Pharmaceuticals Inc. (ACAD) is expected to report first-quarter 2017 results on May 4.
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 9, 2017",2017-05-02 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announce-first-quarter-130000687.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the first quarter ended March 31, 2017 on Tuesday, May 9, 2017, after the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : May 1, 2017",2017-05-01 19:31:44 +0000,http://finance.yahoo.com/r/75ac4296-f006-34d0-b3a9-5f9f7fc3abef/etfs-with-exposure-to-acadia-pharmaceuticals-inc-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals May Just Be the Best Long-Term Play on the Alzheimer's Disease Treatment Market,2017-04-25 13:06:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ENNyCTxZUQY/acadia-pharmaceuticals-may-just-be-the-best-long-term-play-on-the-alzheimers-disease-treatment-market-cm778415,Investor confidence in a potential acquisition of Acadia Pharmaceuticals NASDAQ ACAD seems to have waned and the stock s price has suffered as a result However with share prices at their current depressed level Acadia could be a bargain should its key drug Nuplazid succeed
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals May Just Be the Best Long-Term Play on the Alzheimer&apos;s Disease Treatment Market,2017-04-25 11:25:00 +0000,http://finance.yahoo.com/r/1bb67413-6657-3932-b3ac-6aca1083191d/acadia-pharmaceuticals-may-just-be-the-best-long-t.aspx?yptr=yahoo&.tsrc=rss,"After a significant pullback in April, is now the right time to jump into Acadia?"
ACAD,ACAD:UW,BBG000BHGMW8,Biotech M&A Plunges as Trump Attacks Drug Companies,2017-04-24 10:00:00 +0000,http://finance.yahoo.com/r/36c0c78b-f409-3b03-9601-3f8a62e5a04c/biotech-ma-plunges-trump-attacks-drug-companies?partner=YahooSA&yptr=yahoo&.tsrc=rss,Biotech M&A activity has fallen.
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : April 19, 2017",2017-04-19 18:07:09 +0000,http://finance.yahoo.com/r/1a8b19f9-852a-3d6d-9489-8b93f1495074/etfs-with-exposure-to-acadia-pharmaceuticals-inc-april-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Becomes Oversold (ACAD),2017-04-05 21:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nWspPV93Q2k/acadia-pharmaceuticals-becomes-oversold-acad-cm770445,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : April 5, 2017",2017-04-05 20:14:00 +0000,http://finance.yahoo.com/r/7774aec8-86b2-37af-869b-2dddf9a5b6c7/etfs-with-exposure-to-acadia-pharmaceuticals-inc-april-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Implied IYH Analyst Target Price: $171,2017-04-03 13:35:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lxvlhQOAc8c/implied-iyh-analyst-target-price-171-cm768870,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,What Poker Taught Me About Investing,2017-04-02 18:00:00 +0000,http://realmoney.thestreet.com/articles/04/02/2017/what-poker-taught-me-about-investing?puc=yahoo&cm_ven=YAHOO,What Poker Taught Me About Investing
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers",2017-03-31 21:03:34 +0000,http://biz.yahoo.com/e/170331/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers"
ACAD,ACAD:UW,BBG000BHGMW8,What Does Big Pharma Want To Buy? 3 Drugmakers On Merger Track,2017-03-31 20:10:50 +0000,http://www.investors.com/news/technology/what-does-big-pharma-want-to-buy-3-drugmakers-on-ma-track/?src=A00220A,What Does Big Pharma Want To Buy? 3 Drugmakers On Merger Track
ACAD,ACAD:UW,BBG000BHGMW8,What Does Big Pharma Want To Buy? 3 Drugmakers On Merger Track,2017-03-31 20:10:50 +0000,http://finance.yahoo.com/r/920a231c-0d88-3e9c-bfd6-e62dad8db78b/what-does-big-pharma-want-to-buy-3-drugmakers-on-ma-track?src=A00220A&yptr=yahoo&.tsrc=rss,"Acadia, Intercept and Lexicon could be on the cusp of being acquired, an analyst said Friday as he examined merger patterns in Big Pharma."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer",2017-03-30 12:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announces-appointment-michael-120000740.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced Michael J."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer",2017-03-30 12:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announces-appointment-michael-120000740.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced Michael J."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017",2017-03-29 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-needham-company-130000508.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at Needham & Company’s 16th Annual Healthcare Conference on Wednesday, April 5, 2017, at 10:40 a.m."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017",2017-03-29 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-needham-company-130000508.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at Needham & Company’s 16th Annual Healthcare Conference on Wednesday, April 5, 2017, at 10:40 a.m."
ACAD,ACAD:UW,BBG000BHGMW8,3 Top Biotech Stocks to Buy in 2017,2017-03-26 12:59:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n5gt2a9QAFo/3-top-biotech-stocks-to-buy-in-2017-cm765642,Political uncertainties aside the future is looking bright for the biotech industry Acadia Pharmaceuticals NASDAQ ACAD Regeneron Pharmaceuticals NASDAQ REGN and Eagle Pharmaceuticals NASDAQ EGRX in particular all appear primed for prosperity Here s a
ACAD,ACAD:UW,BBG000BHGMW8,3 Top Biotech Stocks to Buy in 2017,2017-03-26 10:43:00 +0000,http://finance.yahoo.com/r/e806551e-6919-3730-b5a9-6c53068a9726/3-top-biotech-stocks-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss,"Acadia Pharmaceuticals, Regeneron Pharmaceuticals, and Eagle Pharmaceuticals all look like solid choices for the year ahead."
ACAD,ACAD:UW,BBG000BHGMW8,3 Top Biotech Stocks to Buy in 2017,2017-03-26 10:43:00 +0000,https://www.fool.com/investing/2017/03/26/3-top-biotech-stocks-to-buy-in-2017.aspx,3 Top Biotech Stocks to Buy in 2017
ACAD,ACAD:UW,BBG000BHGMW8,Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology,2017-03-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-egalet-receives-us-121500385.html,"[Accesswire] - Upcoming AWS Coverage on ACADIA Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Egalet Corp. (NASDAQ: EGLT ) as ..."
ACAD,ACAD:UW,BBG000BHGMW8,Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology,2017-03-24 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-egalet-receives-us-121500385.html?.tsrc=rss,"Upcoming AWS Coverage on ACADIA Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 24, 2017 / Active Wall St. blog coverage looks at the headline from Egalet Corp. (NASDAQ: EGLT ) as ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 18:25:36 +0000,http://finance.yahoo.com/r/eda788dc-9ae0-3f06-8965-7516f36837da/etfs-with-exposure-to-acadia-pharmaceuticals-inc-march-6-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to ACADIA Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACAD-US. Comparing the performance and risk of ACADIA Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 18:25:36 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-march-6-2017/,"ETFs with exposure to ACADIA Pharmaceuticals, Inc. : March 6, 2017"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA PHARMACEUTICALS INC Financials,2017-03-04 18:04:11 +0000,http://finance.yahoo.com/q/is?s=acad,ACADIA PHARMACEUTICALS INC Financials
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 14:38:17 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017/,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017",2017-03-02 14:38:17 +0000,http://finance.yahoo.com/r/35f4d6ac-de23-3f55-956c-77bb2d5c7114/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q4-2016-by-the-numbers-march-2-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis ACADIA Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ACADIA Pharmaceuticals, Inc. – Vanda Pharmaceuticals Inc., Pfizer Inc., Johnson & Johnson, Eli Lilly and Company and Bristol-Myers Squibb Company (VNDA-US, PFE-US, JNJ-US, LLY-US and BMY-US) that have ... Read more    
<b>(Read more...)</b>"
ACAD,ACAD:UW,BBG000BHGMW8,Analysts Expect BBH Will Reach $134,2017-03-02 14:13:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b81KryS4paA/analysts-expect-bbh-will-reach-134-cm755271,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 28-Feb-17 10:00pm GMT,2017-03-01 01:29:31 +0000,http://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-012931351.html,Edited Transcript of ACAD earnings conference call or presentation 28-Feb-17 10:00pm GMT
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 28-Feb-17 10:00pm GMT,2017-03-01 01:29:31 +0000,http://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-012931351.html?.tsrc=rss,Q4 2016 ACADIA Pharmaceuticals Inc Earnings Call
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an",2017-03-01 00:23:52 +0000,http://biz.yahoo.com/e/170228/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Beats Analysts Estimates,2017-02-28 22:07:00 +0000,http://www.investopedia.com/news/acadia-revenue-beats-estimates-acad/?partner=YahooSA,Acadia Beats Analysts Estimates
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Beats Analysts Estimates,2017-02-28 22:07:00 +0000,http://finance.yahoo.com/r/2643c454-f358-3a8d-bab0-fa18db68cde1/acadia-revenue-beats-estimates-acad?partner=YahooSA&yptr=yahoo&.tsrc=rss,"A recently approved drug, and cash on the books, helped the pharma company grow in 2016."
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today,2017-02-28 22:00:00 +0000,http://biz.yahoo.com/cc/1/155801.html,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
ACAD,ACAD:UW,BBG000BHGMW8,"4:14 pm ACADIA Pharmaceuticals misses by $0.01, beats on revs",2017-02-28 21:14:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#acad,"4:14 pm ACADIA Pharmaceuticals misses by $0.01, beats on revs"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016",2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-reports-financial-results-210500352.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2016."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016",2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-reports-financial-results-210500352.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2016."
ACAD,ACAD:UW,BBG000BHGMW8,"After-Hours Earnings Report for February 28, 2017 :  CRM, ROST, PANW, UHS, TSRO, JAZZ, AR, DXCM, EPR, LOGM, ACAD, BUFF",2017-02-28 20:37:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFc_lxio_H4/after-hours-earnings-report-for-february-28-2017-crm-rost-panw-uhs-tsro-jazz-ar-dxcm-epr-logm-acad-buff-cm754414,The following companies are expected to report earnings after hours on 02 28 2017 Visit our Earnings Calendar for a full list of expected earnings releases Salesforce com Inc CRM is reporting for the quarter ending January 31 2017 The computer
ACAD,ACAD:UW,BBG000BHGMW8,"Earnings Reaction History: ACADIA Pharmaceuticals Inc, 50.0% Follow-Through Indicator, 5.9% Sensitive",2017-02-28 20:09:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tDOr635bwvo/earnings-reaction-history-acadia-pharmaceuticals-inc-500-follow-through-indicator-59-sensitive-cm754448,Expected Earnings Release 02 28 2017 After hoursExpected Earnings Release 02 28 2017 After hours Avg Extended Hours Dollar Volume 2 686 645Avg Extended Hours Dollar Volume 2 686 645 ACADIA Pharmaceuticals Inc ACAD is due to issue its quarterly earnings report in the
ACAD,ACAD:UW,BBG000BHGMW8,Q4 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close,2017-02-28 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=acad,Q4 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017",2017-02-27 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-cowen-company-140000185.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017, at 1:20 p.m."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017",2017-02-27 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-cowen-company-140000185.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017, at 1:20 p.m."
ACAD,ACAD:UW,BBG000BHGMW8,3 Earnings Reports That Should Be on Your Radar,2017-02-24 20:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eH7ap62WmCo/3-earnings-reports-that-should-be-on-your-radar-cm753058,InvestorPlace Stock Market News Stock Advice amp Trading Tips The markets have posted another solid week overall with the S amp P 500 gaining nearly 6 already this year With regards to earnings tech companies largely stole the spotlight with Tesla Inc NASDAQ TSLA cooling
ACAD,ACAD:UW,BBG000BHGMW8,Will Acadia Beat Estimates Again? Maybe.,2017-02-24 18:15:00 +0000,http://finance.yahoo.com/r/1619ddb1-c060-3b7c-96bf-a3d4c3ae5cb1/acadia-pharmaceuticals-q4-preview-acad?partner=YahooSA&yptr=yahoo&.tsrc=rss,Acadia reports fourth quarter results after the closing bell on February 28th and the signs point to another beat for the company.
ACAD,ACAD:UW,BBG000BHGMW8,Will Acadia Beat Estimates Again? Maybe.,2017-02-24 18:15:00 +0000,http://www.investopedia.com/news/acadia-pharmaceuticals-q4-preview-acad/?partner=YahooSA,Will Acadia Beat Estimates Again? Maybe.
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?,2017-02-23 23:49:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6U0jO_CrH2I/acadia-pharma-acad-q4-earnings-whats-in-store-this-time-cm752452,ACADIA Pharmaceuticals Inc ACAD is expected to report fourth quarter 2016 results on Feb 28 The company s track record is dismal ACADIA has missed estimates in all the trailing four quarters bringing the average negative earnings surprise to 19 07 ACADIA s share price increased 35
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?,2017-02-23 21:16:09 +0000,http://finance.yahoo.com/news/acadia-pharma-acad-q4-earnings-211609482.html?.tsrc=rss,ACADIA Pharmaceuticals Inc. (ACAD) is expected to report fourth-quarter 2016 results on Feb 28.
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?,2017-02-23 21:16:09 +0000,http://finance.yahoo.com/news/acadia-pharma-acad-q4-earnings-211609482.html,ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?
ACAD,ACAD:UW,BBG000BHGMW8,First Week of April 21st Options Trading For Acadia Pharmaceuticals,2017-02-22 16:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F-2YbpyZTRQ/first-week-of-april-21st-options-trading-for-acadia-pharmaceuticals-cm751363,Investors in Acadia Pharmaceuticals Inc Symbol ACAD saw new options begin trading this week for the April 21st expiration At Stock Options Channel our YieldBoost formula has looked up and down the ACAD options chain for the new April 21st contracts and identified one put and one
ACAD,ACAD:UW,BBG000BHGMW8,JANA Partners Made Massive New Pharma Investments in Q4,2017-02-21 19:07:00 +0000,http://finance.yahoo.com/r/b1c7d634-a393-377d-be9a-909cc28db66d/jana-partners-made-massive-new-pharma-investments-q4-aet-bmy?partner=YahooSA&yptr=yahoo&.tsrc=rss,Barry Rosenstein's fund picked up new positions in a variety of pharmaceuticals companies in the fourth quarter of last year.
ACAD,ACAD:UW,BBG000BHGMW8,"FBT, ACAD, ALNY, KITE: ETF Outflow Alert",2017-02-21 17:07:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PXpGzWcwQ2Y/fbt-acad-alny-kite-etf-outflow-alert-cm750659,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust NYSE Arca Biotechnology Index Fund Symbol FBT where we have detected an approximate 15 3 million dollar outflow that s a 1 7 decrease week
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017",2017-02-21 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announce-fourth-quarter-140000827.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2016 on Tuesday, February 28, 2017, after the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 28, 2017",2017-02-21 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announce-fourth-quarter-140000827.html?.tsrc=rss,"ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2016 on Tuesday, February 28, 2017, after the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,"Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta",2017-02-17 12:44:00 +0000,https://www.thestreet.com/story/14006436/1/biotech-stock-mailbag-bulls-love-a-distracted-trump-protalix-acadia-sarepta.html?puc=yahoo&cm_ven=YAHOO,"Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta"
ACAD,ACAD:UW,BBG000BHGMW8,"Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta",2017-02-17 12:44:00 +0000,http://finance.yahoo.com/r/75394ba2-12bf-3b03-81fe-8f6983e9cde2/biotech-stock-mailbag-bulls-love-a-distracted-trump-protalix-acadia-sarepta.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Surge Higher Is More Than M&A Rumors,2017-02-16 19:31:00 +0000,http://www.investopedia.com/articles/investing/021617/look-big-gains-acadia-pharmaceuticals-2017-acad.asp?partner=YahooSA,Acadia Pharmaceuticals Surge Higher Is More Than M&A Rumors
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Surge Higher Is More Than M&A Rumors,2017-02-16 19:31:00 +0000,http://finance.yahoo.com/r/0f42d7b1-bf05-3374-b094-00388c96b66e/look-big-gains-acadia-pharmaceuticals-2017-acad.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Shares of ACAD are off to fast start in 2017, but there is more to the story than just M&A activity."
ACAD,ACAD:UW,BBG000BHGMW8,Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade,2017-02-15 22:03:04 +0000,http://finance.yahoo.com/news/price-bump-m-rumors-earns-220304144.html?.tsrc=rss,"The Vetr crowd downgraded their rating for ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) on Wednesday, from 4 stars (Buy), issued nine days ago, to 3 stars (Hold). At the time of the downgrade, crowd confidence ..."
ACAD,ACAD:UW,BBG000BHGMW8,Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade,2017-02-15 22:03:04 +0000,http://finance.yahoo.com/news/price-bump-m-rumors-earns-220304144.html,Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade
ACAD,ACAD:UW,BBG000BHGMW8,Two Great Stock Ideas in the IBB Biotech ETF,2017-02-15 19:44:00 +0000,http://finance.yahoo.com/r/432b3d18-ae85-37e6-a9b8-9e5940f09290/looking-best-stock-ideas-ibb-acad-exel.asp?partner=YahooSA&yptr=yahoo&.tsrc=rss,We take a deep dive into the NASDAQ Biotech ETF (IBB) to look for great investment ideas.
ACAD,ACAD:UW,BBG000BHGMW8,Two Great Stock Ideas in the IBB Biotech ETF,2017-02-15 19:44:00 +0000,http://www.investopedia.com/articles/investing/021517/looking-best-stock-ideas-ibb-acad-exel.asp?partner=YahooSA,Two Great Stock Ideas in the IBB Biotech ETF
ACAD,ACAD:UW,BBG000BHGMW8,Caution: Acadia Pharmaceuticals Is Overvalued,2017-02-15 13:41:42 +0000,http://www.fool.com/investing/2017/02/14/caution-acadia-pharmaceuticals-is-overvalued.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Caution: Acadia Pharmaceuticals Is Overvalued
ACAD,ACAD:UW,BBG000BHGMW8,Caution: Acadia Pharmaceuticals Is Overvalued,2017-02-14 14:19:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SJ6EqVQUWVU/caution-acadia-pharmaceuticals-is-overvalued-cm747447,Shareholders of Acadia Pharmaceuticals NASDAQ ACAD must be riding high after the stock s meteoric run 160 up a massive 29 in the past 3 months While current shareholders are undoubtedly pleased with their returns plenty more eager investors are on the sidelines
ACAD,ACAD:UW,BBG000BHGMW8,A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease,2017-02-12 12:43:11 +0000,http://www.fool.com/investing/2017/02/11/a-potential-20-billion-indication-2-must-have-biot.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease
ACAD,ACAD:UW,BBG000BHGMW8,A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease,2017-02-11 14:17:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2rxVclc7Gv0/a-potential-20-billion-indication-2-must-have-biotechs-taking-on-alzheimers-disease-cm746666,Alzheimer s disease is a terrible illness which affects an estimated 5 4 million Americans today Alzheimer s is also the 6 th leading cause of death nationally Unfortunately there are currently only two types of FDA approved drugs memantine and cholinesterase inhibitors
ACAD,ACAD:UW,BBG000BHGMW8,The Market In 5 Minutes: One For The Thumb,2017-02-06 14:03:00 +0000,http://finance.yahoo.com/news/market-5-minutes-one-thumb-140300899.html,The Market In 5 Minutes: One For The Thumb
ACAD,ACAD:UW,BBG000BHGMW8,"Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet",2017-02-03 18:29:00 +0000,https://www.thestreet.com/story/13982370/1/acadia-pops-on-takeout-rumors-but-don-t-buy-on-m-amp-a-just-yet.html?puc=yahoo&cm_ven=YAHOO,"Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet"
ACAD,ACAD:UW,BBG000BHGMW8,"Notable ETF Inflow Detected - XBI, CLVS, ACAD, UTHR",2017-02-02 17:32:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pakwiJavqtM/notable-etf-inflow-detected-xbi-clvs-acad-uthr-cm742278,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the XBI SPDR S amp P Biotech ETF US Equities Symbol XBI where we have detected an approximate 136 6 million dollar inflow that s a 5 3 increase week over week
ACAD,ACAD:UW,BBG000BHGMW8,Forget GW Pharmaceuticals -- These 2 Stocks Are Better Buys,2017-02-02 16:34:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8wLR44vzXPQ/forget-gw-pharmaceuticals-these-2-stocks-are-better-buys-cm742231,Britain s GW Pharmaceuticals NASDAQ GWPH has certainly captured the market s imagination with its cannabidiol drug development platform Over the past three years its stock is up by an astounding 1200 GWPH data by YCharts Although
ACAD,ACAD:UW,BBG000BHGMW8,Forget GW Pharmaceuticals -- These 2 Stocks Are Better Buys,2017-02-02 15:53:57 +0000,http://www.fool.com/investing/2017/02/02/forget-gw-pharmaceuticals-these-2-stocks-are-bette.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Forget GW Pharmaceuticals -- These 2 Stocks Are Better Buys
ACAD,ACAD:UW,BBG000BHGMW8,Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys,2017-02-02 15:45:14 +0000,http://www.fool.com/investing/2017/02/01/forget-anavex-life-sciences-corp-these-2-biotech-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys
ACAD,ACAD:UW,BBG000BHGMW8,3 Big Mergers & Acquisitions That We Could See in 2017,2017-02-01 22:31:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OAB8Tc8p5dE/3-big-mergers-acquisitions-that-we-could-see-in-2017-cm741892,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It looks like 2017 is likely to be a big year for mergers amp acquisitions Several factors have come together over the past few months that have made the coming year ripe for consolidation Industries
ACAD,ACAD:UW,BBG000BHGMW8,Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys,2017-02-01 17:33:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SsTqLg6e0PY/forget-anavex-life-sciences-corp-these-2-biotech-stocks-are-better-buys-cm741643,Investors are right to focus on potential Alzheimer s disease drugs because of the huge market but Anavex Life Sciences Corp NASDAQ AVXL is an awfully long way from from the finish line with its lead candidate Clinical stage biotech stocks are inherently risky but I d like to
ACAD,ACAD:UW,BBG000BHGMW8,Biotech Acquisitions on the Rise in 2017: Latest Reports on Antares Pharma and ACADIA Pharmaceuticals,2017-01-31 14:30:00 +0000,http://finance.yahoo.com/news/biotech-acquisitions-rise-2017-latest-143000311.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 31, 2017 / Biotech acquisitions deals are expected to see a substantial jump in 2017 as large pharmaceutical companies look to boost slowing revenues. Already in January ..."
ACAD,ACAD:UW,BBG000BHGMW8,How Risky Is Acadia Pharmaceuticals Stock?,2017-01-31 13:12:51 +0000,http://www.fool.com/investing/2017/01/30/how-risky-is-acadia-pharmaceuticals-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Risky Is Acadia Pharmaceuticals Stock?
ACAD,ACAD:UW,BBG000BHGMW8,How Risky Is Acadia Pharmaceuticals Stock?,2017-01-30 14:34:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3xlNO9Y9ysg/how-risky-is-acadia-pharmaceuticals-stock-cm740003,Acadia Pharmaceuticals NASDAQ ACAD is probably in better shape now than it s ever been The biotech won approval last year for its lead product Nuplazid in treating Parkinson s disease psychosis Acadia s stock is up more than 30 over the past 12 months Additional studies
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals (ACAD) Shares Cross Above 200 DMA,2017-01-26 18:32:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cXKNBPflfyw/acadia-pharmaceuticals-acad-shares-cross-above-200-dma-cm738833,In trading on Thursday shares of Acadia Pharmaceuticals Inc Symbol ACAD crossed above their 200 day moving average of 31 32 changing hands as high as 32 10 per share Acadia Pharmaceuticals Inc shares are currently trading up about 0 8 on the day The chart below shows the one
ACAD,ACAD:UW,BBG000BHGMW8,Top Biotech Stocks to Buy in 2017,2017-01-23 19:16:31 +0000,http://www.fool.com/investing/2017/01/22/top-biotech-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Biotech Stocks to Buy in 2017
ACAD,ACAD:UW,BBG000BHGMW8,Top Biotech Stocks to Buy in 2017,2017-01-23 12:53:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bfUvky1en4o/top-biotech-stocks-to-buy-in-2017-cm736463,The past 18 months haven t been very pleasant for biotech investors The SPDR S amp P Biotech ETF NYSEMKT XBI has fallen nearly 30 from its all time highs set back in the summer of 2015 Many individual biotech stocks have performed far worse One bright side to all of
ACAD,ACAD:UW,BBG000BHGMW8,Surprising Analyst 12-Month Target For FBT,2017-01-19 15:38:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--htUzDVHwk/surprising-analyst-12-month-target-for-fbt-cm735428,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016,2017-01-14 13:25:26 +0000,http://www.fool.com/investing/2017/01/13/why-acadia-pharmaceuticals-inc-stock-slipped-19-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016
ACAD,ACAD:UW,BBG000BHGMW8,Why Acadia Pharmaceuticals Inc. Stock Slipped 19% in 2016,2017-01-13 14:39:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k2kjv-9yHK8/why-acadia-pharmaceuticals-inc-stock-slipped-19-in-2016-cm733164,Image source Getty Images What happened Shares of Acadia Pharmaceuticals Inc NASDAQ ACAD a biopharmaceutical company focused on treating central nervous system disorders fell 19 1 last year according to 160 data from S amp P Global Market
ACAD,ACAD:UW,BBG000BHGMW8,Top Stocks to Buy in 2017,2017-01-08 17:12:08 +0000,http://www.fool.com/investing/2017/01/07/top-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Stocks to Buy in 2017
ACAD,ACAD:UW,BBG000BHGMW8,3 Companies Whose Sales Could Double in 2017,2017-01-08 16:43:21 +0000,http://www.fool.com/investing/2017/01/07/3-companies-whose-sales-could-double-in-2017-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Companies Whose Sales Could Double in 2017
ACAD,ACAD:UW,BBG000BHGMW8,Top Stocks to Buy in 2017,2017-01-07 18:49:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l9_gd_tgDL0/top-stocks-to-buy-in-2017-cm730742,Obamacare uncertainty and pushback on drug prices sent shockwaves through the healthcare sector in 2016 Will 2017 be a better year for investors Washington s passage of the 21st Century Cures Act potential insurance reform and key data on game changing drugs could make or break
ACAD,ACAD:UW,BBG000BHGMW8,3 Companies Whose Sales Could Double in 2017,2017-01-07 17:49:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xtjmV6QLU4o/3-companies-whose-sales-could-double-in-2017-cm730730,While companies that promise 160 triple digit sales growth are rare they do exist In fact market watchers currently believe that ACADIA Pharmaceuticals NASDAQ ACAD NovoCure Ltd NASDAQ NVCR and Intercept Pharmaceuticals NASDAQ ICPT will all pull off that feat
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals' Alzheimer's Data Raises Some Questions,2017-01-06 15:39:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ywKdSiQVbGs/acadia-pharmaceuticals-alzheimers-data-raises-some-questions-cm730325,Acadia Pharmaceuticals NASDAQ ACAD recently reported intriguing mid stage study data for Nuplazid in Alzheimer s disease psychosis which sent shares surging higher However the trial results do raise some important questions regarding the durability of Nuplazid s benefit and
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals' Alzheimer's Data Raises Some Questions,2017-01-06 14:10:21 +0000,http://www.fool.com/investing/2017/01/06/acadias-alzheimers-disease-data-raises-some-questi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Acadia Pharmaceuticals' Alzheimer's Data Raises Some Questions
ACAD,ACAD:UW,BBG000BHGMW8,3 ideas to improve waiting for your trades,2017-01-05 21:51:58 +0000,http://finance.yahoo.com/tumblr/blog-3-ideas-to-improve-waiting-for-your-trades-215209047.html,3 ideas to improve waiting for your trades
ACAD,ACAD:UW,BBG000BHGMW8,First Week of ACAD February 17th Options Trading,2017-01-05 17:40:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eqba3wbNmVk/first-week-of-acad-february-17th-options-trading-cm729923,Investors in Acadia Pharmaceuticals Inc Symbol ACAD saw new options become available this week for the February 17th expiration At Stock Options Channel our YieldBoost formula has looked up and down the ACAD options chain for the new February 17th contracts and identified one put and
ACAD,ACAD:UW,BBG000BHGMW8,#1 issue top traders want to fix in 2017 on our prop desk,2017-01-05 16:13:40 +0000,http://finance.yahoo.com/tumblr/blog-1-issue-top-traders-want-to-fix-in-2017-on-our-182805496.html,#1 issue top traders want to fix in 2017 on our prop desk
ACAD,ACAD:UW,BBG000BHGMW8,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle",2017-01-05 14:13:45 +0000,http://finance.yahoo.com/news/market-5-minutes-jobless-claims-141345184.html,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle"
ACAD,ACAD:UW,BBG000BHGMW8,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today",2017-01-05 00:37:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LlN5h8WL298/why-encana-acadia-pharmaceuticals-and-tenet-healthcare-jumped-today-cm729594,The stock market continued to perform well on Wednesday sending the S amp P 500 to within a point of a new all time record closing high The Dow remained stubbornly below 20 000 but major market benchmarks posted gains of around half a percent as the latest release of minutes from
ACAD,ACAD:UW,BBG000BHGMW8,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today,2017-01-04 23:37:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CbCwZqXYfu8/heres-why-acadia-pharmaceuticals-inc-stock-is-up-today-cm729584,Image source Getty Images What happened Shares of ACADIA Pharmaceuticals Inc NASDAQ ACAD popped just ahead of lunch on Wednesday and have risen about 12 6 as of 3 31 p m EST An unconfirmed rumor that Pfizer is interested in acquiring its set to explode
ACAD,ACAD:UW,BBG000BHGMW8,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today",2017-01-04 23:17:00 +0000,http://www.fool.com/investing/2017/01/04/why-encana-acadia-pharmaceuticals-and-tenet-health.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today"
ACAD,ACAD:UW,BBG000BHGMW8,Exploring an Apple Inc. (AAPL) Takeover of Sirius and Pandora,2017-01-04 22:37:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nUI56dWkTkA/exploring-an-apple-inc-aapl-takeover-of-sirius-and-pandora-cm729567,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc NASDAQ AAPL stock improved 10 in 2016 despite posting its first revenue decline since 2001 Last week it emerged that Apple would cut iPhone 7 production 10 amid
ACAD,ACAD:UW,BBG000BHGMW8,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today,2017-01-04 21:43:52 +0000,http://www.fool.com/investing/2017/01/04/heres-why-acadia-pharmaceuticals-inc-stock-is-up-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout,2017-01-04 21:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jM8VZLSiCQE/acadia-pharmaceuticals-inc-acad-flirts-with-a-pfizer-inc-pfe-buyout-cm729528,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Acadia Pharmaceuticals Inc 160 NASDAQ ACAD is having a Happy New Year as ACAD stock 160 sets the second trading day of the year ablaze with 12 plus gains It won
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ACAD,2017-01-04 18:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GqWXPePWb0E/acadia-pharmaceuticals-breaks-above-200-day-moving-average-bullish-for-acad-cm729456,In trading on Wednesday shares of Acadia Pharmaceuticals Inc Symbol ACAD crossed above their 200 day moving average of 30 88 changing hands as high as 31 60 per share Acadia Pharmaceuticals Inc shares are currently trading up about 8 3 on the day The chart below shows the one
ACAD,ACAD:UW,BBG000BHGMW8,"Wednesday's ETF Movers: XBI, XLE",2017-01-04 18:37:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sX3kPjb0BQU/wednesdays-etf-movers-xbi-xle-cm729441,In trading on Wednesday the SPDR S amp P Biotech ETF is outperforming other ETFs up about 4 5 on the day Components of that ETF showing particular strength include shares of Acadia Pharmaceuticals up about 10 1 and shares of Exact Sciences up about 10 on the day And
ACAD,ACAD:UW,BBG000BHGMW8,Wednesday's ETF with Unusual Volume: FNX,2017-01-04 18:36:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eHyG1q-UNA0/wednesdays-etf-with-unusual-volume-fnx-cm729437,The First Trust Mid Cap Core AlphaDEX Fund ETF is seeing unusually high volume in afternoon trading Wednesday with over 292 000 shares traded versus three month average volume of about 53 000 Shares of FNX were up about 1 3 on the day Components of that ETF with the highest volume
ACAD,ACAD:UW,BBG000BHGMW8,Biotech Stocks to Watch in 2017 ACADIA Pharmaceuticals and Exelixis,2017-01-04 14:15:00 +0000,http://finance.yahoo.com/news/biotech-stocks-watch-2017-acadia-141500730.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 4, 2017 / The Biotech Industry posted a sharp loss in 2016 as concerns over price gouging plagued the Industry. The iShares NASDAQ Biotechnology Index ETF (IBB) fell ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 10, 2017",2017-01-03 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-35th-annual-140000035.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 35th Annual J.P."
ACAD,ACAD:UW,BBG000BHGMW8,Vetr Still Bullish On Acadia Despite Downgrade,2016-12-28 12:18:51 +0000,http://finance.yahoo.com/news/vetr-still-bullish-acadia-despite-121851295.html,Vetr Still Bullish On Acadia Despite Downgrade
ACAD,ACAD:UW,BBG000BHGMW8,4 Biotech Stocks to Buy in January,2016-12-27 13:52:18 +0000,http://www.fool.com/investing/2016/12/26/4-biotech-stocks-to-buy-in-january.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Biotech Stocks to Buy in January
ACAD,ACAD:UW,BBG000BHGMW8,4 Biotech Stocks to Buy in January,2016-12-26 14:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NflNs50fciM/4-biotech-stocks-to-buy-in-january-cm726063,When an entire sector goes on sale it tends to create bargains There s no doubt that the biotech sector has the blue light special flashing right now as it has massively underperformed the S amp P 500 year to date Knowing that we asked a team of healthcare contributors
ACAD,ACAD:UW,BBG000BHGMW8,3 Companies Whose Revenue Could Double in 2017,2016-12-24 14:51:43 +0000,http://www.fool.com/investing/2016/12/23/3-companies-whose-revenue-could-double-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Companies Whose Revenue Could Double in 2017
ACAD,ACAD:UW,BBG000BHGMW8,3 Companies Whose Revenue Could Double in 2017,2016-12-23 15:59:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tkz2iuQlsag/3-companies-whose-revenue-could-double-in-2017-cm725659,Image source Getty Images The definition of a high growth stock can vary depending on who you ask but companies on such a list should be growing sales at a consistent double digit clip at the least Then again there are always outliers Biopharma companies with a new product
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint,2016-12-21 17:00:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lJJ55JUbzfo/acadia-phase-ii-alzheimers-drug-hits-primary-endpoint-cm724573,ACADIA Pharmaceuticals Inc ACAD announced that a phase II exploratory study 019 Study evaluating pimavanserin for the treatment of Alzheimer s disease psychosis AD Psychosis met the primary endpoint Following the news ACADIA shares rose more than 12 In fact the biotech company
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint,2016-12-21 15:07:03 +0000,http://finance.yahoo.com/news/acadia-phase-ii-alzheimers-drug-150703983.html,ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint
ACAD,ACAD:UW,BBG000BHGMW8,Today's Reports on Biotech Movers ACADIA Pharmaceuticals and Conatus Pharmaceuticals,2016-12-21 14:15:00 +0000,http://finance.yahoo.com/news/todays-reports-biotech-movers-acadia-141500937.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 21, 2016 / After many years of impressive gains for investors the Biotech Industry has experienced downward pressure in 2016. The iShares NASDAQ Biotechnology Index ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Jumps Following Phase II Alzheimer's Study,2016-12-21 04:22:00 +0000,http://www.investopedia.com/news/acad-shares-following-positive-results-acad/?partner=YahooSA,Acadia Jumps Following Phase II Alzheimer's Study
ACAD,ACAD:UW,BBG000BHGMW8,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date",2016-12-20 23:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nKXhi36iXl0/akba-inks-blockbuster-deal-agn-on-buying-spree-tsro-gets-fda-date-20161220-01025,"AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date"
ACAD,ACAD:UW,BBG000BHGMW8,Why ACADIA Pharmaceuticals Inc. Is Soaring Today,2016-12-20 20:57:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0GHiHXEKiSk/why-acadia-pharmaceuticals-inc-is-soaring-today-cm724241,Image source Getty Images What happened After releasing encouraging data from an important Phase II clinical trial shares of Acadia Pharmaceuticals NASDAQ ACAD rose by 14 as of 10 10 a m EST on Tuesday So what Acadia released top line results from
ACAD,ACAD:UW,BBG000BHGMW8,Why ACADIA Pharmaceuticals Inc. Is Soaring Today,2016-12-20 19:52:36 +0000,http://www.fool.com/investing/2016/12/20/why-acadia-pharmaceuticals-inc-is-soaring-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why ACADIA Pharmaceuticals Inc. Is Soaring Today
ACAD,ACAD:UW,BBG000BHGMW8,"Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Manager’s Top Stock Picks for 2017",2016-12-20 17:16:06 +0000,http://www.insidermonkey.com/blog/tesla-motors-inc-tsla-netflix-acadia-pharmaceuticals-this-hedge-fund-managers-top-stock-picks-for-2017-512245/,"Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Manager’s Top Stock Picks for 2017"
ACAD,ACAD:UW,BBG000BHGMW8,Dow And Nasdaq Reach New Record Closing Highs - U.S. Commentary,2016-12-20 16:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W9Vh-Soisug/dow-and-nasdaq-reach-new-record-closing-highs--us-commentary-20161220-00857,Dow And Nasdaq Reach New Record Closing Highs - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharma Takes Low Road to Justify Drug Push Into Alzheimer's Psychosis,2016-12-20 14:48:00 +0000,https://www.thestreet.com/story/13932719/1/acadia-pharma-takes-low-road-to-justify-drug-push-into-alzheimer-s-pyschosis.html?puc=yahoo&cm_ven=YAHOO,Acadia Pharma Takes Low Road to Justify Drug Push Into Alzheimer's Psychosis
ACAD,ACAD:UW,BBG000BHGMW8,"Wall Street Sees Higher Open, Uncertainty Looms After Terror Attacks in Berlin, Zurich, Ankara",2016-12-20 14:36:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WLvlM3PbY0o/wall-street-sees-higher-open-uncertainty-looms-after-terror-attacks-in-berlin-zurich-ankara-cm723863,U S stocks were pointing to a higher open on Tuesday in a typically quiet trading period before the holiday season and as uncertainty reigned on investors after separate terror attacks in Berlin Zurich and Ankara on Monday U S stocks were pointing to a higher open on Tuesday in a typically
ACAD,ACAD:UW,BBG000BHGMW8,UPDATE 1-Acadia says Alzheimer's disease psychosis drug clears study,2016-12-20 14:22:22 +0000,http://finance.yahoo.com/news/acadia-says-alzheimers-disease-psychosis-133925210.html,UPDATE 1-Acadia says Alzheimer's disease psychosis drug clears study
ACAD,ACAD:UW,BBG000BHGMW8,"Health Care Sector Update for 12/20/2016: BMY, ACAD, JNJ, PFE, ABT, MRK, AMGN",2016-12-20 14:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FaAJRv6k-Kw/health-care-sector-update-for-12202016-bmy-acad-jnj-pfe-abt-mrk-amgn-cm723794,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN 1 7 AMGN 1 7 Health care shares were mixed in pre market trade Tuesday Health care shares were mixed in pre market trade Tuesday In health care stocks
ACAD,ACAD:UW,BBG000BHGMW8,"US Futures Point North, Uncertainty Looms After Terror Attacks in Berlin, Zurich, Ankara",2016-12-20 13:57:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fP3oCAl8WtY/us-futures-point-north-uncertainty-looms-after-terror-attacks-in-berlin-zurich-ankara-cm723766,U S stock futures point north on Tuesday in a typically quiet trading period before the holiday season and as uncertainty reigned on investors after separate terror attacks in Berlin Zurich and Ankara on Monday U S stock futures point north on Tuesday in a typically quiet trading period
ACAD,ACAD:UW,BBG000BHGMW8,"Pre-Market Most Active for Dec 20, 2016 :  AZN, ACAD, RAD, CNAT, ABB, BAC, GFI, MO, TVIX, BBRY, NVDA, XIV",2016-12-20 13:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_o8z0CZpMqs/pre-market-most-active-for-dec-20-2016-azn-acad-rad-cnat-abb-bac-gfi-mo-tvix-bbry-nvda-xiv-cm723767,The NASDAQ 100 Pre Market Indicator is up 7 07 to 4 941 92 The total Pre Market volume is currently 12 859 084 shares traded The following are the most active stocks for the pre market session Astrazeneca PLC AZN is 0 19 at 27 14 with 5 192 937 shares traded
ACAD,ACAD:UW,BBG000BHGMW8,Alzheimer's disease psychosis drug clears mid-stage study -Acadia,2016-12-20 12:40:36 +0000,http://finance.yahoo.com/news/alzheimers-disease-psychosis-drug-clears-124036325.html,Alzheimer's disease psychosis drug clears mid-stage study -Acadia
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Announces Positive Top-Line Results From Phase II Study of Pimavanserin for Alzheimer’s Disease Psychosis,2016-12-20 12:32:06 +0000,http://www.publicnow.com/view/051E0163C688120713B312053597F32A1BE0290E,"[at noodls] - Data Support Moving Forward With Further Development in Alzheimer's Disease Psychosis Conference Call and Webcast to Be Held Today, December 20, 2016, at 8:30 a.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Dec. ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-20 12:26:11 +0000,http://biz.yahoo.com/e/161220/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Give Back Ground But Remain Mostly Positive - U.S. Commentary,2016-12-20 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Da4RGvnGATE/stocks-give-back-ground-but-remain-mostly-positive--us-commentary-20161220-00645,Stocks Give Back Ground But Remain Mostly Positive - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Dow And Nasdaq Reach New Record Intraday Highs - U.S. Commentary,2016-12-20 10:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZFyYQ1Jxga8/dow-and-nasdaq-reach-new-record-intraday-highs--us-commentary-20161220-00575,Dow And Nasdaq Reach New Record Intraday Highs - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc. (ACAD) Is Up Sharply On Phase 2 Study Results,2016-12-20 09:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8g6mD-wcYkA/acadia-pharmaceuticals-inc-acad-is-up-sharply-on-phase-2-study-results-20161220-00525,ACADIA Pharmaceuticals Inc. (ACAD) Is Up Sharply On Phase 2 Study Results
ACAD,ACAD:UW,BBG000BHGMW8,Futures Pointing To Early Strength On Wall Street - U.S. Commentary,2016-12-20 08:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9rSkUAQ7tO0/futures-pointing-to-early-strength-on-wall-street--us-commentary-20161220-00394,Futures Pointing To Early Strength On Wall Street - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?,2016-12-19 18:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZgH2g8Y0h-A/acadia-pharmaceuticals-incs-stock-has-fallen-27-in-2016-have-we-hit-bottom-cm723424,2016 was suppose to be a 160 breakout year for ACADIA Pharmaceuticals NASDAQ ACAD but it s turned out to be a bust instead Shares of the commercial stage biopharma focused on diseases of the central nervous system 160 have traded erratically all year long and they
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?,2016-12-19 16:26:06 +0000,http://www.fool.com/investing/2016/12/19/acadia-pharmaceuticals-stock-has-fallen-30-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom?
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : December 19, 2016",2016-12-19 15:25:10 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-value-analysis-nasdaqacad-december-19-2016/,"ACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : December 19, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement",2016-12-16 21:59:21 +0000,http://biz.yahoo.com/e/161216/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 16, 2016",2016-12-16 12:10:09 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-acad-us-december-16-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 16, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,3 Beaten-Up Biotech Stocks: Are They Bargains?,2016-12-10 16:05:04 +0000,http://www.fool.com/investing/2016/12/09/3-beaten-up-biotech-stocks-are-they-bargains-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Up Biotech Stocks: Are They Bargains?
ACAD,ACAD:UW,BBG000BHGMW8,3 Beaten-Up Biotech Stocks: Are They Bargains?,2016-12-09 17:58:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QHpJx3kLxNw/3-beaten-up-biotech-stocks-are-they-bargains-cm719395,Looking for cheap biotech stocks Shares of ACADIA Pharmaceuticals NASDAQ ACAD Agenus Inc NASDAQ AGEN and Geron Corp NASDAQ GERN have all taken big hits over the past few months Image source Getty Images There are reasons to suspect all
ACAD,ACAD:UW,BBG000BHGMW8,From Hype To Flop: 10 Biotech Stops That Let Down Investors In 2016,2016-12-07 05:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vxgHkCpzlNM/from-hype-to-flop-10-biotech-stops-that-let-down-investors-in-2016-20161207-00107,From Hype To Flop: 10 Biotech Stops That Let Down Investors In 2016
ACAD,ACAD:UW,BBG000BHGMW8,What's behind put volume in Acadia,2016-12-06 13:16:26 +0000,http://finance.yahoo.com/news/whats-behind-put-volume-acadia-131626732.html,What's behind put volume in Acadia
ACAD,ACAD:UW,BBG000BHGMW8,Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November,2016-12-05 14:01:06 +0000,http://www.fool.com/investing/2016/12/05/heres-why-acadia-pharmaceuticals-inc-jumped-177-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 5, 2016",2016-12-05 12:06:14 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-acad-us-december-5-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : December 5, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Major Depressive Disorder,2016-12-01 15:22:56 +0000,http://www.publicnow.com/view/94C6AD19DDFA6B74FA583740CB8B9CEA6B0A0E1E,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Dec. 1, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system ..."
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Major Depressive Disorder,2016-12-01 14:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-initiates-phase-ii-140000522.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system disorders, today announced the initiation of CLARITY, a Phase II study to evaluate pimavanserin for adjunctive treatment in patients with major depressive disorder who have an inadequate response to first-line therapies for clinical depression."
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotechs With Save-the-Date Catalysts on Tap,2016-11-30 17:34:00 +0000,http://www.fool.com/investing/2016/11/29/3-biotechs-with-save-the-date-catalysts-on-tap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs With Save-the-Date Catalysts on Tap
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotechs With Save-the-Date Catalysts on Tap,2016-11-29 18:55:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-nRUicSUZ7g/3-biotechs-with-save-the-date-catalysts-on-tap-cm715250,Image source Getty Images If a potential catalyst brings good news in a biotech stock investors can make a fortune In fact if the market likes what it hears expect investors to 160 stampede into the stock in masses 160 But what if the news 160 on a key data release or
ACAD,ACAD:UW,BBG000BHGMW8,Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD),2016-11-28 13:42:33 +0000,http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-acadia-pharmaceuticals-inc-acad-2-490800/,Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
ACAD,ACAD:UW,BBG000BHGMW8,5 Biotech Stocks George Soros Is Buying,2016-11-23 15:29:28 +0000,http://www.fool.com/investing/2016/11/22/5-biotech-stocks-george-soros-is-buying.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Biotech Stocks George Soros Is Buying
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : November 23, 2016",2016-11-23 12:32:54 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-november-23-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : November 23, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,5 Biotech Stocks George Soros Is Buying,2016-11-22 23:19:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ttlUPyNBqXQ/5-biotech-stocks-george-soros-is-buying-cm713020,George Soros namesake fund known as Soros Fund Management has continued to show interest in the beaten down biotech space this year even as most of its hedge fund peers have run for cover due to the political headwinds emanating from the U S presidential election
ACAD,ACAD:UW,BBG000BHGMW8,What''s In The Offing For These Biotech Stocks?,2016-11-22 11:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Aodj8q9A-uA/whats-in-the-offing-for-these-biotech-stocks-20161122-00774,What''s In The Offing For These Biotech Stocks?
ACAD,ACAD:UW,BBG000BHGMW8,Ready to Get In on Biotech? Check Out These 3 Stocks,2016-11-21 12:03:50 +0000,http://www.fool.com/investing/2016/11/20/ready-to-get-in-on-biotech-check-out-these-3-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Ready to Get In on Biotech? Check Out These 3 Stocks
ACAD,ACAD:UW,BBG000BHGMW8,Ready to Get In on Biotech? Check Out These 3 Stocks,2016-11-20 12:50:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gaEmWvHvzM/ready-to-get-in-on-biotech-check-out-these-3-stocks-cm711663,There 160 are plenty of reasons for investors to avoid the biotechnology sector altogether The majority of companies from the industry are unprofitable forcing them to constantly raise additional capital Bringing a new drug through the regulatory approval process is
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Starts Phase II Schizophrenia Study on Pimavanserin,2016-11-16 16:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZxNlUIH8Vgw/acadia-starts-phase-ii-schizophrenia-study-on-pimavanserin-cm710080,ACADIA Pharmaceuticals Inc ACAD announced the initiation of a phase II study ADVANCE to evaluate pimavanserin for treating patients with negative symptoms of schizophrenia ADVANCE is a randomized double blind placebo controlled and multi center study designed for examining the
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Starts Phase II Schizophrenia Study on Pimavanserin,2016-11-16 14:16:02 +0000,http://finance.yahoo.com/news/acadia-starts-phase-ii-schizophrenia-141602437.html,ACADIA Starts Phase II Schizophrenia Study on Pimavanserin
ACAD,ACAD:UW,BBG000BHGMW8,Blog Coverage Viking Presents New Clinical Data on VK2809,2016-11-16 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-viking-presents-clinical-131500613.html,"[Accesswire] - Upcoming AWS Coverage on ACADIA Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / November 16, 2016 / Active Wall St. blog coverage looks at the headline from Viking Therapeutics, Inc. (NASDAQ: ..."
ACAD,ACAD:UW,BBG000BHGMW8,"Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects",2016-11-15 20:19:02 +0000,http://www.insidermonkey.com/blog/johnson-johnson-jnj-acadia-pharmaceuticals-inc-acad-healthcare-experts-at-march-altus-like-these-and-other-healthcare-stocks-prospects-488262/,"Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia,2016-11-15 14:08:09 +0000,http://www.publicnow.com/view/31BF6C4EF17C13E7A0F5743FE628FB0116F13126,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 15, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Faces Education Battle With Parkinson's Drug: Goldman,2016-11-11 21:08:02 +0000,http://www.investors.com/news/technology/acadia-faces-education-battle-with-parkinsons-drug-goldman/,Acadia Faces Education Battle With Parkinson's Drug: Goldman
ACAD,ACAD:UW,BBG000BHGMW8,Coverage initiated on ACADIA Pharmaceuticals by Goldman,2016-11-11 12:53:13 +0000,http://finance.yahoo.com/q/ud?s=ACAD,Coverage initiated on ACADIA Pharmaceuticals by Goldman
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : November 11, 2016",2016-11-11 12:14:34 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-acad-us-november-11-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : November 11, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,ACAD Crosses Above Key Moving Average Level,2016-11-10 20:13:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vAvaKuAA4LE/acad-crosses-above-key-moving-average-level-cm707383,In trading on Thursday shares of Acadia Pharmaceuticals Inc Symbol ACAD crossed above their 200 day moving average of 29 44 changing hands as high as 30 23 per share Acadia Pharmaceuticals Inc shares are currently trading up about 1 4 on the day The chart below shows the one
ACAD,ACAD:UW,BBG000BHGMW8,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : November 10, 2016",2016-11-10 16:56:50 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-november-10-2016/,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : November 10, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016",2016-11-09 15:16:30 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q3-2016-by-the-numbers-november-9-2016/,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,Here's What Caused ACADIA Pharmaceuticals to Drop 27% in October,2016-11-09 00:54:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iY6WCd9tkfc/heres-what-caused-acadia-pharmaceuticals-to-drop-27-in-october-cm706025,Image source Getty Images What happened In the wake of launching its Parkinson s disease drug Nuplazid on its own and ahead of third quarter financial results ACADIA Pharmaceuticals Inc NASDAQ ACAD 160 shares tumbled 26 7 last month 160 according to S amp
ACAD,ACAD:UW,BBG000BHGMW8,Here's What Caused ACADIA Pharmaceuticals to Drop 27% in October,2016-11-08 22:41:05 +0000,http://www.fool.com/investing/2016/11/08/heres-what-caused-acadia-pharmaceuticals-to-drop-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's What Caused ACADIA Pharmaceuticals to Drop 27% in October
ACAD,ACAD:UW,BBG000BHGMW8,"Health Care Sector Update for 11/08/2016: ACAD,OSIR,BIOS",2016-11-08 21:35:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ooph4dnbs5I/health-care-sector-update-for-11082016-acadosirbios-cm705924,Top Health Care StocksTop Health Care Stocks JNJ 0 47 JNJ 0 47 PFE 0 12 PFE 0 12 MRK 0 15 MRK 0 15 ABT 0 87 ABT 0 87 AMGN 0 19 AMGN 0 19 Health care stocks were ending higher for a third day in a row with the NYSE Health Care Index rising slightly over 0 3 while shares of
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Shares Soar as Nuplazid Sales Easily Top Estimates,2016-11-08 20:37:00 +0000,https://www.thestreet.com/story/13885448/1/acadia-shares-soar-as-nuplazid-sales-easily-top-estimates.html?puc=yahoo&cm_ven=YAHOO,Acadia Shares Soar as Nuplazid Sales Easily Top Estimates
ACAD,ACAD:UW,BBG000BHGMW8,Why Acadia Pharmaceuticals Stock Is Surging Today,2016-11-08 20:35:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OAixDzVnHrI/why-acadia-pharmaceuticals-stock-is-surging-today-cm705889,Image source Getty Images What happened As of 11 35 a m EST shares of Acadia Pharmaceuticals NASDAQ ACAD a mid cap biopharma 160 were up by nearly 18 The biotech s surge northward was sparked by a stellar third quarter earnings release where the company s
ACAD,ACAD:UW,BBG000BHGMW8,Why Acadia Pharmaceuticals Stock Is Surging Today,2016-11-08 16:40:14 +0000,http://www.fool.com/investing/2016/11/08/why-acadia-pharmaceuticals-stock-is-surging-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Acadia Pharmaceuticals Stock Is Surging Today
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Close Mostly Higher After Seeing Early Weakness - U.S. Commentary,2016-11-08 16:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BUVyeedIN9o/stocks-close-mostly-higher-after-seeing-early-weakness--us-commentary-20161108-01178,Stocks Close Mostly Higher After Seeing Early Weakness - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Jumps on Incredible Earnings,2016-11-08 16:05:08 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-jumps-incredible-earnings-160508082.html,Acadia Pharmaceuticals Jumps on Incredible Earnings
ACAD,ACAD:UW,BBG000BHGMW8,Acadia's Valuation Looks Pretty Attractive Right Now: Bank Of America Upgrades To Buy,2016-11-08 15:55:19 +0000,http://finance.yahoo.com/news/acadias-valuation-looks-pretty-attractive-155519890.html,Acadia's Valuation Looks Pretty Attractive Right Now: Bank Of America Upgrades To Buy
ACAD,ACAD:UW,BBG000BHGMW8,"Analysts' Actions -- Bank of America, Depomed, Hertz, AT&T and More",2016-11-08 13:15:00 +0000,http://finance.yahoo.com/news/analysts-actions-bank-america-depomed-131500406.html,"Analysts' Actions -- Bank of America, Depomed, Hertz, AT&T and More"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Show Significant Turnaround After Early Pullback - U.S. Commentary,2016-11-08 12:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8VN_A2F7c1Y/stocks-show-significant-turnaround-after-early-pullback--us-commentary-20161108-00896,Stocks Show Significant Turnaround After Early Pullback - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc. (ACAD) Is Rising On Strong Q3 Revenues,2016-11-08 09:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z37ysuN3N8s/acadia-pharmaceuticals-inc-acad-is-rising-on-strong-q3-revenues-20161108-00732,ACADIA Pharmaceuticals Inc. (ACAD) Is Rising On Strong Q3 Revenues
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 7-Nov-16 10:00pm GMT,2016-11-08 01:37:51 +0000,http://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-013751708.html,Edited Transcript of ACAD earnings conference call or presentation 7-Nov-16 10:00pm GMT
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 3Q loss,2016-11-07 22:48:55 +0000,http://sg.finance.yahoo.com/news/acadia-reports-3q-loss-224855757.html,Acadia reports 3Q loss
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharma's sales come twice as much as expected,2016-11-07 22:01:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9EF0019A-8A91-4234-B0A8-ED0D79D689C7&siteid=yhoof2,Acadia Pharma's sales come twice as much as expected
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today,2016-11-07 22:00:00 +0000,http://biz.yahoo.com/cc/6/154686.html,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an",2016-11-07 21:36:45 +0000,http://biz.yahoo.com/e/161107/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results,2016-11-07 21:20:07 +0000,http://www.publicnow.com/view/AFC9B83A89C46DC616E131D986EEC51146F8D01D,[at noodls] - NUPLAZID Net Product Sales Grew to $5.3 Million in the First Full Quarter of Commercialization Expanding Pimavanserin Clinical Program With Initiation of Studies for Alzheimer's Disease Agitation and Adjunctive ...
ACAD,ACAD:UW,BBG000BHGMW8,"Earnings Reaction History: ACADIA Pharmaceuticals Inc, 42.9% Follow-Through Indicator, 5.0% Sensitive",2016-11-07 20:13:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xWGlN-80nBo/earnings-reaction-history-acadia-pharmaceuticals-inc-429-follow-through-indicator-50-sensitive-cm705219,Expected Earnings Release 11 07 2016 After hoursExpected Earnings Release 11 07 2016 After hours Avg Extended Hours Dollar Volume 1 924 505Avg Extended Hours Dollar Volume 1 924 505 ACADIA Pharmaceuticals Inc ACAD is due to issue its quarterly earnings report in the
ACAD,ACAD:UW,BBG000BHGMW8,Q3 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close,2016-11-07 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=acad,Q3 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
ACAD,ACAD:UW,BBG000BHGMW8,Arena (ARNA) Q3 Earnings: Will the Stock Pull a Surprise?,2016-11-04 20:39:08 +0000,http://finance.yahoo.com/news/arena-arna-q3-earnings-stock-203908459.html,Arena (ARNA) Q3 Earnings: Will the Stock Pull a Surprise?
ACAD,ACAD:UW,BBG000BHGMW8,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More",2016-11-04 14:15:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ybyP7kU5h3I/drug-stocks-earnings-roster-for-nov-7-hznp-acad-more-cm704072,The bulk of the Q3 earnings season is over with 364 S amp P 500 members as of Nov 2 accounting for 72 6 of the index s total market capitalization having already reported results according to the latest Earnings Outlook While total earnings for these index members were up 1 6 from
ACAD,ACAD:UW,BBG000BHGMW8,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More",2016-11-04 12:54:12 +0000,http://finance.yahoo.com/news/drug-stocks-earnings-roster-nov-125412689.html,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More"
ACAD,ACAD:UW,BBG000BHGMW8,What to Expect from Repros (RPRX) This Earnings Season,2016-11-04 11:38:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zkay5GSbqWQ/what-to-expect-from-repros-rprx-this-earnings-season-cm703822,Repros Therapeutics Inc RPRX is expected to report third quarter 2016 results on Nov 14 The company has reported an average positive surprise of 24 56 in the last two quarters Let s see how things are shaping up for this quarter Factors at Play Repros is a development stage
ACAD,ACAD:UW,BBG000BHGMW8,Puma Biotechnology (PBYI) Q3 Earnings: What's in Store?,2016-11-04 00:07:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Ct6Nz9fV04/puma-biotechnology-pbyi-q3-earnings-whats-in-store-cm703729,Puma Biotechnology Inc PBYI is expected to report third quarter 2016 results in November The company s track record has been mostly disappointing While it missed estimates in two of the trailing four quarters it met the same in one and surpassed in the other The company recorded an
ACAD,ACAD:UW,BBG000BHGMW8,What to Expect from Repros (RPRX) This Earnings Season,2016-11-03 22:27:10 +0000,http://finance.yahoo.com/news/expect-repros-rprx-earnings-season-222710003.html,What to Expect from Repros (RPRX) This Earnings Season
ACAD,ACAD:UW,BBG000BHGMW8,Will Juno Therapeutics (JUNO) Disappoint in Q3 Earnings?,2016-11-03 14:10:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v_398me66Yw/will-juno-therapeutics-juno-disappoint-in-q3-earnings-cm703257,Juno Therapeutics Inc JUNO will be reporting third quarter 2016 results on Nov 9 after the market closes Last quarter the company posted a negative earnings surprise of 27 5 The company started trading in Dec 2014 So far it has had a poor track record with the company
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia,2016-11-03 13:08:10 +0000,http://www.publicnow.com/view/5AE8E342F017EBEDF3A7EF11A12BD9DFA9ED3500,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 3, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous system ..."
ACAD,ACAD:UW,BBG000BHGMW8,9 Biotech Stocks to Put on Your Radar,2016-11-02 13:50:02 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S015-9-biotech-stocks-to-put-on-your-radar/index.html?rid=SYN-yahoo&rpageid=15589,9 Biotech Stocks to Put on Your Radar
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 7, 2016",2016-11-01 13:35:10 +0000,http://www.publicnow.com/view/02B27A4276637C89BE14A398E4DFE6A575851966,"[at noodls] - ACADIA to Host Conference Call and Webcast on Monday, November 7, 2016, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Nov. 1, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ARIA To Face FDA In April, OPXA''s Woes Continue, Keep An Eye On OPHT",2016-11-01 01:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KtfqL-CRm-k/aria-to-face-fda-in-april-opxas-woes-continue-keep-an-eye-on-opht-20161101-01238,"ARIA To Face FDA In April, OPXA''s Woes Continue, Keep An Eye On OPHT"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?,2016-10-31 14:16:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QrdDpzGVf7Y/acadia-pharma-acad-will-it-disappoint-in-q3-earnings-cm700962,ACADIA Pharmaceuticals Inc ACAD is expected to report third quarter 2016 results on Nov 3 In the four trailing quarters the company has missed estimates thrice bringing the average negative earnings surprise to 15 72 ACADIA PHARMA Price and EPS
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?,2016-10-31 13:23:01 +0000,http://finance.yahoo.com/news/acadia-pharma-acad-disappoint-q3-132301678.html,ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation,2016-10-31 13:13:05 +0000,http://www.publicnow.com/view/286E4C0E8EB7CDFC09E71EDD2EA7C55AD3D25644,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Oct. 31, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in central nervous ..."
ACAD,ACAD:UW,BBG000BHGMW8,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock,2016-10-28 13:44:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WcxrjgQexpI/3-charts-that-show-why-to-buy-acadia-pharmaceuticals-stock-cm700020,Why should an investor consider buying ACADIA Pharmaceuticals NASDAQ ACAD stock Not because the biotech s Nuplazid stormed out of the gate after winning FDA approval in April It didn t There are reasons to buy ACADIA though These three charts show why the biotech stock
ACAD,ACAD:UW,BBG000BHGMW8,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock,2016-10-28 12:36:59 +0000,http://www.fool.com/investing/2016/10/28/3-charts-that-show-why-to-buy-acadia-pharmaceutica.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Charts That Show Why to Buy ACADIA Pharmaceuticals Stock
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Becomes Oversold,2016-10-27 21:42:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/szjpjfytJxk/acadia-pharmaceuticals-becomes-oversold-cm699807,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ACAD,ACAD:UW,BBG000BHGMW8,"Commit To Purchase Acadia Pharmaceuticals At $20, Earn 45.1% Annualized Using Options",2016-10-19 16:46:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Daq1hv8yIWo/commit-to-purchase-acadia-pharmaceuticals-at-20-earn-451-annualized-using-options-cm695378,Investors eyeing a purchase of Acadia Pharmaceuticals Inc Symbol ACAD shares but tentative about paying the going market price of 23 38 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ACAD,ACAD:UW,BBG000BHGMW8,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : October 19, 2016",2016-10-19 14:40:40 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-october-19-2016/,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : October 19, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Continue To Show A Lack Of Direction - U.S. Commentary,2016-10-12 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MFnOssxx3hg/stocks-continue-to-show-a-lack-of-direction--us-commentary-20161012-00372,Stocks Continue To Show A Lack Of Direction - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Receives California Life Sciences Association’s 2016 Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID™,2016-10-11 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-receives-california-life-130000463.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, has been awarded the California Life Sciences Association’s 2016 Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID™ , the first and only drug approved by the U.S."
ACAD,ACAD:UW,BBG000BHGMW8,The Implied Analyst 12-Month Target For IWR,2016-10-10 14:18:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNxqUamnBOI/the-implied-analyst-12-month-target-for-iwr-cm690987,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
ACAD,ACAD:UW,BBG000BHGMW8,These 2 Biotechs Could Vanish by 2018,2016-10-07 00:43:22 +0000,http://www.fool.com/investing/2016/10/06/these-2-biotechs-could-vanish-by-2018.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 2 Biotechs Could Vanish by 2018
ACAD,ACAD:UW,BBG000BHGMW8,These 2 Biotechs Could Vanish by 2018,2016-10-06 15:46:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D9qA-LHVsz0/these-2-biotechs-could-vanish-by-2018-cm689767,Investors hoping to suss out the next Amgen or Gilead Sciences that is companies that start small but grow into multi billion dollar entities can be in for rough ride After all most early life cycle biotechs tend to meet one of two less glamorous fates bankruptcy
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Enters Oversold Territory (ACAD),2016-10-05 17:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tt05uv0xBd0/acadia-pharmaceuticals-enters-oversold-territory-acad-cm689267,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ACAD,ACAD:UW,BBG000BHGMW8,10 Biotech Stocks to Put on Your Radar This Quarter,2016-10-04 20:46:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n7v6LCPRO3c/10-biotech-stocks-to-put-on-your-radar-this-quarter-cm688122,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips While the foreseeable future for the broad market may not be clear there s one group that still moves independently of stocks as a whole biotech stocks
ACAD,ACAD:UW,BBG000BHGMW8,Notable Two Hundred Day Moving Average Cross - ACAD,2016-10-04 18:43:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V23j2fiQgXg/notable-two-hundred-day-moving-average-cross-acad-cm688654,In trading on Tuesday shares of Acadia Pharmaceuticals Inc Symbol ACAD crossed below their 200 day moving average of 30 16 changing hands as low as 28 83 per share Acadia Pharmaceuticals Inc shares are currently trading down about 4 7 on the day The chart below shows the one
ACAD,ACAD:UW,BBG000BHGMW8,3 Top Biotech Stocks to Buy in October,2016-10-03 19:13:02 +0000,http://www.fool.com/investing/2016/10/02/3-top-biotech-stocks-to-buy-in-october.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Biotech Stocks to Buy in October
ACAD,ACAD:UW,BBG000BHGMW8,3 Top Biotech Stocks to Buy in October,2016-10-02 20:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KBVGAIpI0zk/3-top-biotech-stocks-to-buy-in-october-cm687545,Image source Getty Images The biotech industry is on pace for a down year The First Trust NYSE Arca Biotech ETF NYSEMKT FBT an exchange traded fund that holds a broad portfolio of biotech stocks has descended by double digits since the start of 2016 badly lagging the S amp
ACAD,ACAD:UW,BBG000BHGMW8,The Market In 5 Minutes: OPEC's Deal And Gary Johnson's Moment,2016-09-29 13:00:59 +0000,http://finance.yahoo.com/news/market-5-minutes-opecs-deal-130059032.html,The Market In 5 Minutes: OPEC's Deal And Gary Johnson's Moment
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : September 29, 2016",2016-09-29 12:31:51 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-september-29-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : September 29, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Seeing Modest Weakness Following Yellen Comments - U.S. Commentary,2016-09-28 12:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-tiFcv6cqwo/stocks-seeing-modest-weakness-following-yellen-comments--us-commentary-20160928-00715,Stocks Seeing Modest Weakness Following Yellen Comments - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails,2016-09-23 20:07:24 +0000,http://www.investors.com/news/technology/axovant-confidence-not-swayed-after-rival-alzheimers-drug-fails/,Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails
ACAD,ACAD:UW,BBG000BHGMW8,A Critical Couple of Months for Acadia Pharmaceuticals,2016-09-22 22:22:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oNUPweUbBME/a-critical-couple-of-months-for-acadia-pharmaceuticals-cm683473,Image source Stockmonkeys com via Flickr ACADIA Pharmaceuticals NASDAQ ACAD 160 investors have a lot of news to look forward to over the coming months The company recently launched Nuplazid a 160 Parkinson s disease psychosis therapy and Q3 results should provide
ACAD,ACAD:UW,BBG000BHGMW8,A Critical Couple of Months for Acadia Pharmaceuticals,2016-09-22 20:40:06 +0000,http://www.fool.com/investing/general/2016/09/22/a-critical-couple-of-months-for-acadia-pharmaceuti.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Critical Couple of Months for Acadia Pharmaceuticals
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016",2016-09-20 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-ladenburg-thalmann-130000293.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016, at 9:00 a.m."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : September 19, 2016",2016-09-19 15:07:26 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-value-analysis-nasdaqacad-september-19-2016/,"ACADIA Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACAD) : September 19, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Sponsors National Parkinson Foundation’s Caregiver Summit,2016-09-19 13:18:02 +0000,http://www.publicnow.com/view/CE4F52FEE1EFA73B81DEED97B06E12D151621DC1,"[at noodls] - ACADIA to Host Booths and Present Posters at the 4World Parkinson Congress SAN DIEGO--(BUSINESS WIRE)--Sep. 19, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : September 16, 2016",2016-09-16 12:19:27 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-acad-us-september-16-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : September 16, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Regaining Ground Following Yesterday's Pullback - U.S. Commentary,2016-09-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uJdhMkp1X30/stocks-regaining-ground-following-yesterdays-pullback--us-commentary-20160914-00690,Stocks Regaining Ground Following Yesterday's Pullback - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Regaining Ground Following Yesterday's Pullback - U.S. Commentary,2016-09-14 10:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MFkyr843Nok/stocks-regaining-ground-following-yesterdays-pullback--us-commentary-20160914-00691,Stocks Regaining Ground Following Yesterday's Pullback - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,3 Stocks Begging for a Buyout,2016-09-12 11:54:30 +0000,http://www.fool.com/investing/2016/09/11/3-stocks-begging-for-a-buyout.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks Begging for a Buyout
ACAD,ACAD:UW,BBG000BHGMW8,Why ACADIA Pharmaceuticals Tumbled 13.3% in August,2016-09-11 14:30:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QT8xDvs_WRQ/why-acadia-pharmaceuticals-tumbled-133-in-august-cm677449,Image source Getty Images What happened After reporting second quarter results and announcing a 200 million dilutive stock offering ACADIA Pharmaceuticals Inc NASDAQ ACAD fell 13 3 last month 160 according to S amp P Global Market Intelligence So what
ACAD,ACAD:UW,BBG000BHGMW8,3 Stocks Begging for a Buyout,2016-09-11 13:30:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IcfQ8KVkAnE/3-stocks-begging-for-a-buyout-cm677444,Investors should never buy a stock solely because there s a chance that a suitor will buy the company lock stock and barrel However that doesn t mean that a stock that may attract an acquirer won t also appeal to investors For instance our Motley Fool contributors think that
ACAD,ACAD:UW,BBG000BHGMW8,Why ACADIA Pharmaceuticals Tumbled 13.3% in August,2016-09-11 12:40:06 +0000,http://www.fool.com/investing/2016/09/11/why-acadia-pharmaceuticals-tumbled-133-in-august.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why ACADIA Pharmaceuticals Tumbled 13.3% in August
ACAD,ACAD:UW,BBG000BHGMW8,3 Mid-Cap Healthcare Stocks You Can Buy Right Now,2016-09-10 17:29:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QjdQSsBmGQk/3-mid-cap-healthcare-stocks-you-can-buy-right-now-cm677402,Image source Getty Images Many investors prefer large cap stocks as the underlying companies tend to be mature and stable However it s a mistake to overlook mid cap stocks which 160 are generally defined as having a market capitalization of between 2 billion and 10
ACAD,ACAD:UW,BBG000BHGMW8,3 Mid-Cap Healthcare Stocks You Can Buy Right Now,2016-09-10 16:09:56 +0000,http://www.fool.com/investing/2016/09/10/3-mid-cap-healthcare-stocks-you-can-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Mid-Cap Healthcare Stocks You Can Buy Right Now
ACAD,ACAD:UW,BBG000BHGMW8,5 Stocks to Trade for Big Breakout Gains,2016-09-09 14:59:00 +0000,https://www.thestreet.com/story/13699728/1/5-stocks-to-trade-for-big-breakout-gains.html?puc=yahoo&cm_ven=YAHOO,5 Stocks to Trade for Big Breakout Gains
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2016",2016-09-06 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-present-morgan-stanley-130000353.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016, at 12:30 p.m."
ACAD,ACAD:UW,BBG000BHGMW8,Better Buy: ACADIA Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc.,2016-09-04 11:50:42 +0000,http://www.fool.com/investing/2016/09/03/better-buy-acadia-pharmaceuticals-vs-sarepta-thera.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: ACADIA Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc.
ACAD,ACAD:UW,BBG000BHGMW8,Better Buy: ACADIA Pharmaceuticals Inc. vs. Sarepta Therapeutics Inc.,2016-09-03 13:17:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NLJ30vxH-ZM/better-buy-acadia-pharmaceuticals-inc-vs-sarepta-therapeutics-inc-cm674435,Image source Getty Images ACADIA Pharmaceuticals NASDAQ ACAD and Sarepta Therapeutics NASDAQ SRPT 160 are both cash burning biotech stocks that offer huge upside if everything goes according to plan However shareholders in each company face a real risk of being
ACAD,ACAD:UW,BBG000BHGMW8,3 Stocks That Could Make You Rich,2016-09-01 12:05:24 +0000,http://www.fool.com/investing/2016/08/31/3-stocks-that-could-make-you-rich.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Could Make You Rich
ACAD,ACAD:UW,BBG000BHGMW8,3 Stocks That Could Make You Rich,2016-08-31 13:12:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3YBgB6d0e_M/3-stocks-that-could-make-you-rich-cm672655,"Image source  Getty Images.  Most investors who want to become wealthy shouldn't be in a rush to do so. After all, the market's movements are impossible to predict, so it makes sense to construct a"
ACAD,ACAD:UW,BBG000BHGMW8,"3 Stocks Up Over 1,000% in the Past 5 Years",2016-08-28 12:11:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ctsOQzD6Oio/3-stocks-up-over-1000-in-the-past-5-years-cm671276,"Image source  Getty Images.  Past performance doesn't guarantee supersize gains (or losses) in the future, but investors who took the risk and socked these three darlings into their portfolios five years ago are"
ACAD,ACAD:UW,BBG000BHGMW8,"3 Stocks Up Over 1,000% in the Past 5 Years",2016-08-28 10:49:39 +0000,http://www.fool.com/investing/2016/08/28/3-stocks-up-over-1000-in-the-past-5-years.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Stocks Up Over 1,000% in the Past 5 Years"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 25, 2016",2016-08-25 12:05:54 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-august-25-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 25, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,"CFO Moves: Acadia Pharmaceuticals, Liberty Global",2016-08-25 11:18:21 +0000,http://blogs.wsj.com/cfo/2016/08/25/cfo-moves-acadia-pharmaceuticals-liberty-global/?mod=yahoo_hs,"CFO Moves: Acadia Pharmaceuticals, Liberty Global"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers",2016-08-24 20:23:10 +0000,http://biz.yahoo.com/e/160824/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer",2016-08-24 13:28:05 +0000,http://www.publicnow.com/view/B4D961050B6D8C400F4827CC3C5E258188350445,"[at noodls] - http://www.businesswire.com/news/home/20160824005294/en/ Todd S. Young, Executive Vice President, Chief Financial Officer of ACADIA Pharmaceuticals (Photo: Business Wire) 'Todd is a seasoned leader with ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer",2016-08-24 13:00:00 +0000,http://finance.yahoo.com/news/acadia-pharmaceuticals-announces-appointment-todd-130000726.html,"[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced the appointment of Todd S."
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotech Stocks With Explosive Upside Potential,2016-08-23 21:46:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5_y8QCugfBI/3-biotech-stocks-with-explosive-upside-potential-cm669231,Image source  Getty Images.  The biotech sector is a great hunting ground for investors who are after stocks that offer massive upside. If you buy shares in a company that goes on to create
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares,2016-08-23 20:58:02 +0000,http://www.publicnow.com/view/DF477F8B9277569555A4D83EDCE9274DF7B96CDE,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Aug. 23, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet ..."
ACAD,ACAD:UW,BBG000BHGMW8,3 Biotech Stocks With Explosive Upside Potential,2016-08-23 19:41:00 +0000,http://www.fool.com/investing/2016/08/23/3-biotech-stocks-with-explosive-upside-potential.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotech Stocks With Explosive Upside Potential
ACAD,ACAD:UW,BBG000BHGMW8,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : August 22, 2016",2016-08-22 14:59:28 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-august-22-2016/,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : August 22, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,The 10 Best Small- and Mid-Cap Stocks to Buy Now,2016-08-20 02:46:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mcqQEgPGwnI/the-10-best-small-and-mid-cap-stocks-to-buy-now-cm668066,"Small  and mid cap stocks are known for their high risk, sure. But they're also known as being excellent stocks to buy for their"
ACAD,ACAD:UW,BBG000BHGMW8,Director takes a bigger stake in ACADIA Pharmaceuticals,2016-08-18 16:49:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/omrew8s9jc4/director-takes-a-bigger-stake-in-acadia-pharmaceuticals-cm667225,"Baker Brothers, holder of a Director seat  at ACADIA Pharmaceuticals ( ACAD ), bought 1,303,030 shares of the company's common stock on August 10. The shares were purchased at $33.00 for a total of  $42,999,990.00.     InvestorsKeyhole Trade"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares,2016-08-15 14:01:40 +0000,http://www.insidermonkey.com/blog/acadia-pharmaceuticals-acad-baker-bros-advisors-buys-more-shares-468920/,Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
ACAD,ACAD:UW,BBG000BHGMW8,5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call,2016-08-11 14:51:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9uDmEOxh9wc/5-cant-miss-quotes-from-acadia-pharmaceuticals-incs-q2-investor-call-cm663976,Image source  ACADIA Pharmaceuticals.  It's an interesting time to be an investor in ACADIA Pharmaceuticals (NASDAQ  ACAD) . The company is in the middle of transforming itself from a clinical stage enterprise into a
ACAD,ACAD:UW,BBG000BHGMW8,5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call,2016-08-11 13:05:00 +0000,http://www.fool.com/investing/2016/08/11/5-cant-miss-quotes-from-acadia-pharmaceuticals-inc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-10 20:51:23 +0000,http://biz.yahoo.com/e/160810/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ACAD,ACAD:UW,BBG000BHGMW8,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : August 10, 2016",2016-08-10 19:29:14 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-august-10-2016/,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : August 10, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016",2016-08-10 15:01:30 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-acad-us-earnings-analysis-q2-2016-by-the-numbers-august-10-2016/,"ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Prices Public Offering of Common Stock,2016-08-10 01:10:08 +0000,http://www.publicnow.com/view/4B85CCECCBF3F759EC87D94E6B7492DC2A1BF98C,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Aug. 9, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 9, 2016",2016-08-09 12:22:38 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-acad-us-august-9-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 9, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock,2016-08-08 20:08:03 +0000,http://www.publicnow.com/view/9C121E2C7E3D782C3F1EAE4D20EA729F50F29611,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Aug. 8, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet ..."
ACAD,ACAD:UW,BBG000BHGMW8,Edited Transcript of ACAD earnings conference call or presentation 4-Aug-16 9:00pm GMT,2016-08-05 20:13:30 +0000,http://finance.yahoo.com/news/edited-transcript-acad-earnings-conference-201330388.html,Edited Transcript of ACAD earnings conference call or presentation 4-Aug-16 9:00pm GMT
ACAD,ACAD:UW,BBG000BHGMW8,"Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today",2016-08-05 16:42:31 +0000,http://www.insidermonkey.com/blog/why-2u-take-two-acadia-air-lease-and-acxiom-are-making-headlines-today-467778/,"Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 2Q loss,2016-08-04 23:01:46 +0000,http://sg.finance.yahoo.com/news/acadia-reports-2q-loss-230146588.html,Acadia reports 2Q loss
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today,2016-08-04 21:00:00 +0000,http://biz.yahoo.com/cc/0/153320.html,ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results,2016-08-04 20:33:11 +0000,http://www.publicnow.com/view/AAE74E6E31946F6710692660E2135A89DD938C55,"[at noodls] - Quarter highlighted by approval and launch of NUPLAZID™ (pimavanserin) in the United States, the first and only FDA-approved drug for the treatment of hallucinations and delusions associated with Parkinson's ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an",2016-08-04 20:14:35 +0000,http://biz.yahoo.com/e/160804/acad8-k.html,"ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an"
ACAD,ACAD:UW,BBG000BHGMW8,"Earnings Reaction History: ACADIA Pharmaceuticals Inc, 37.5% Follow-Through Indicator, 4.8% Sensitive",2016-08-04 19:09:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKpImnBw7fo/earnings-reaction-history-acadia-pharmaceuticals-inc-375-follow-through-indicator-48-sensitive-cm660651,"Expected Earnings Release 08 04 2016, After hours Avg. Extended Hours Dollar Volume $1,620,961 ACADIA Pharmaceuticals Inc ( ACAD ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
ACAD,ACAD:UW,BBG000BHGMW8,Q2 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close,2016-08-04 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20160804.html?t=acad,Q2 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
ACAD,ACAD:UW,BBG000BHGMW8,5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More,2016-08-03 15:59:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PYcNWphP2W0/5-drug-stocks-to-watch-for-earnings-on-aug-4-bmrn-more-cm659656,"With Q2 earnings season drawing to a close, we have seen about 317 S&P 500 members (representing 73.5% of the index's total market capitalization) announce quarterly results as of Jul 29. Reported results show a 3.3% year over year"
ACAD,ACAD:UW,BBG000BHGMW8,5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More,2016-08-03 13:36:01 +0000,http://finance.yahoo.com/news/5-drug-stocks-watch-earnings-133601603.html,5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?,2016-08-02 13:59:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uy3Mr873voM/acadia-acad-q2-earnings-whats-in-store-for-the-stock-cm658615,"ACADIA Pharmaceuticals Inc.ACAD is scheduled to report second quarter 2016 results on Aug 4 after the market closes . In the last reported quarter, ACADIA had posted a negative earnings surprise of 12.5%. Let's see how things are shaping"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?,2016-08-02 11:54:11 +0000,http://finance.yahoo.com/news/acadia-acad-q2-earnings-whats-115411500.html,ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016",2016-07-29 22:38:02 +0000,http://www.publicnow.com/view/1719A479DA7FA322FF1A1DB48E7D9F9825CA22B6,"[at noodls] - ACADIA to Host Conference Call and Webcast on Thursday, August 4, 2016, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Jul. 29, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : July 26, 2016",2016-07-26 16:38:05 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-acadia-pharmaceuticals-inc-july-26-2016/,"ETF’s with exposure to ACADIA Pharmaceuticals, Inc. : July 26, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,These 3 Biotechs Have Automatic Demand,2016-07-23 16:09:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/htNAc611718/these-3-biotechs-have-automatic-demand-cm653738,"It takes real skill to market a drug or medical device properly, and sales can greatly suffer if a company doesn't do it right. A marketing miscue can turn even the best drug or medical device into"
ACAD,ACAD:UW,BBG000BHGMW8,These 3 Biotechs Have Automatic Demand,2016-07-23 14:41:00 +0000,http://www.fool.com/investing/2016/07/23/these-3-biotechs-have-automatic-demand.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Biotechs Have Automatic Demand
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : July 22, 2016",2016-07-22 12:08:30 +0000,http://www.capitalcube.com/blog/index.php/acadia-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-acad-us-july-22-2016/,"ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : July 22, 2016"
ACAD,ACAD:UW,BBG000BHGMW8,Stocks Close Higher Following Upbeat Earnings News - U.S. Commentary,2016-07-20 16:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2vWr3T0fDOc/stocks-close-higher-following-upbeat-earnings-news--us-commentary-20160720-01030,Stocks Close Higher Following Upbeat Earnings News - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,"Wednesday's ETF Movers: XBI, GDXJ",2016-07-20 16:09:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HQ-0wcgi-U8/wednesdays-etf-movers-xbi-gdxj-cm651940,"In trading on Wednesday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 2.2% on the day. Components of that ETF showing particular strength include shares of Progenics Pharma ( PGNX ), up about"
ACAD,ACAD:UW,BBG000BHGMW8,"Stocks Remain Mostly Positive, Adding To Recent Gains - U.S. Commentary",2016-07-20 12:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1cwPHZXjrk/stocks-remain-mostly-positive-adding-to-recent-gains--us-commentary-20160720-00731,"Stocks Remain Mostly Positive, Adding To Recent Gains - U.S. Commentary"
ACAD,ACAD:UW,BBG000BHGMW8,Upbeat Earnings News Leads To Early Strength On Wall Street - U.S. Commentary,2016-07-20 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4pL1iurCVi0/upbeat-earnings-news-leads-to-early-strength-on-wall-street--us-commentary-20160720-00634,Upbeat Earnings News Leads To Early Strength On Wall Street - U.S. Commentary
ACAD,ACAD:UW,BBG000BHGMW8,"Commit To Buy Acadia Pharmaceuticals At $18, Earn 11.4% Using Options",2016-07-19 17:12:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vJAfJrbuJGc/commit-to-buy-acadia-pharmaceuticals-at-18-earn-114-using-options-cm651421,"Investors eyeing a purchase of Acadia Pharmaceuticals Inc (Symbol ACAD) shares, but cautious about paying the going market price of $32.98 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract"
ACAD,ACAD:UW,BBG000BHGMW8,This Could Be the Next Big Pharma Buyout,2016-07-18 19:13:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sERSuxc3jVg/this-could-be-the-next-big-pharma-buyout-cm650764,Photo source  Getty images.  Remember the days when the mindset of Big Pharma was to just do deals? It didn't matter what you did    you just had to do something.
ACAD,ACAD:UW,BBG000BHGMW8,3 Risky Biotech Stocks That Could Make You Rich,2016-07-12 21:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9m0zO4G9r1U/3-risky-biotech-stocks-that-could-make-you-rich-cm648245,"Image Source  Getty Images  If you're looking for stocks that offer unusual growth opportunities, clinical stage biotechs are fertile ground. Even among this select group, though, there are only a handful of companies"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Inc.: Why ACAD Stock Will Be Volatile Over the Next Year,2016-07-05 21:47:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qq6Jp-rFajY/acadia-pharmaceuticals-inc-why-acad-stock-will-be-volatile-over-the-next-year-cm644920,Acadia Pharmaceuticals Inc. ( ACAD ) has been the model of inconsistency and unpredictability over the last year.   ACAD is currently trading right
ACAD,ACAD:UW,BBG000BHGMW8,These 3 Biotech Stocks Are Ridiculously Cheap Now,2016-07-05 13:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ugcHxFXXmI/these-3-biotech-stocks-are-ridiculously-cheap-now-cm644529,"Image source  Getty Images.  The Brexit vote may have sent global markets into a tailspin, but that's no reason to panic. After all, there are still plenty of solid companies to buy at"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why,2016-06-28 17:49:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yAGCp1Teia4/acadia-pharmaceuticals-incs-shareholders-are-having-a-crazy-year-heres-why-cm642183,"Image source  Acadia Pharmaceuticals.  What   It's been a wild year for shareholders of Acadia Pharmaceuticals (NASDAQ  ACAD) , a commercial stage biopharma focused on diseases of the central nervous system. Shares plunged"
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Added to Large-Cap Russell 1000 Market Index,2016-06-27 13:11:05 +0000,http://www.publicnow.com/view/586485BBEE1B022BC30B548C378FA4A1562FBB29,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Jun. 27, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016",2016-06-16 14:39:12 +0000,http://www.publicnow.com/view/637496A3BBE6489FDD00FACD244A4F5A3BF7A1A5,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Jun. 16, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ..."
ACAD,ACAD:UW,BBG000BHGMW8,"Noteworthy ETF Inflows: XBI, ACAD, ANAC, MDVN",2016-06-15 17:01:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/43OAbtjv2_M/noteworthy-etf-inflows-xbi-acad-anac-mdvn-cm635888,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Biotech ETF (Symbol XBI) where we have detected an approximate $90.0 million dollar inflow"
ACAD,ACAD:UW,BBG000BHGMW8,Is Acadia Pharmaceuticals' Stock Still a Buy?,2016-06-12 13:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xpXZiJMTvrs/is-acadia-pharmaceuticals-stock-still-a-buy-cm634211,"Image Source  Getty Images  What Acadia Pharmaceuticals '(NASDAQ  ACAD) stock rose by nearly 10% last month, according to data from S&P Global Market Intelligence . The biotech's monthly surge was fueled by"
ACAD,ACAD:UW,BBG000BHGMW8,Acadia Pharmaceuticals Inc.: 7 Companies That Could Buy ACAD,2016-06-08 23:13:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ibvxiOjezR4/acadia-pharmaceuticals-inc-7-companies-that-could-buy-acad-cm632611,Acadia Pharmaceuticals Inc. ( ACAD ) surged over $40 for the first time since last November on a report that  AstraZeneca plc (ADR) ( AZN
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016",2016-06-01 13:13:12 +0000,http://www.publicnow.com/view/15C51ACA442B2819A5F434A9B624455CFE9E7EB6,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Jun. 1, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ..."
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Announces NUPLAZID™ (pimavanserin) Is Now Available for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis,2016-05-31 12:12:02 +0000,http://www.publicnow.com/view/8853388C0493E6A219CFE5488D70EDFC98AB3D08,"[at noodls] - NUPLAZID is the First and Only FDA-Approved Drug for this Indication An Estimated 40 Percent of Parkinson's Disease Patients Have Psychosis SAN DIEGO--(BUSINESS WIRE)--May 31, 2016-- ACADIA Pharmaceuticals ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 1Q loss,2016-05-05 21:44:37 +0000,http://sg.finance.yahoo.com/news/acadia-reports-1q-loss-214437210.html,Acadia reports 1Q loss
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016",2016-05-04 13:20:05 +0000,http://www.publicnow.com/view/51364B7DB126C944B241C03D706E68EF5F188352,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--May 4, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 5, 2016",2016-05-02 20:30:13 +0000,http://www.publicnow.com/view/38D8FF56856618B2941E07C600989C2F202433E5,"[at noodls] - ACADIA to Host Conference Call and Webcast on Thursday, May 5, 2016, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--May 2, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical ..."
ACAD,ACAD:UW,BBG000BHGMW8,FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis,2016-04-29 23:39:43 +0000,http://www.publicnow.com/view/C2B7283621E3C6E7D752BD65AFD7BBCAB90645F3,[at noodls] - http://www.businesswire.com/news/home/20160429006144/en/ NUPLAZID™ (pimavanserin) bottle (Photo: Business Wire) 'Today's approval of NUPLAZID represents a major paradigm shift in the treatment of Parkinson's ...
ACAD,ACAD:UW,BBG000BHGMW8,First drug for delusions in Parkinson's patients approved,2016-04-29 21:55:38 +0000,http://sg.finance.yahoo.com/news/first-drug-delusions-parkinsons-patients-215538506.html,First drug for delusions in Parkinson's patients approved
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016",2016-04-06 13:20:12 +0000,http://www.publicnow.com/view/9BE9C933DB6A55020A025545EB28E9A1CB1F5C3A,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Apr. 6, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ..."
ACAD,ACAD:UW,BBG000BHGMW8,FDA Advisory Committee Votes 12 to 2 That Benefits of ACADIA Pharmaceuticals’ NUPLAZID™ (Pimavanserin) for the Treatment of Psychosis Associated with Parkinson’s Disease Outweigh the Risks,2016-03-29 21:37:18 +0000,http://www.publicnow.com/view/A43EB331244E24EB99473DAD2A43B581C4156C37,"[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Mar. 29, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet ..."
ACAD,ACAD:UW,BBG000BHGMW8,Gov't panel backs drug for delusions in Parkinson's patients,2016-03-29 21:28:52 +0000,http://sg.finance.yahoo.com/news/govt-panel-backs-drug-delusions-195136010.html,Gov't panel backs drug for delusions in Parkinson's patients
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Stock Trading Halted Today,2016-03-29 11:13:26 +0000,http://www.publicnow.com/view/E5B4A3634D0F50AF88F32F17DF0B58931FDEE57C,"[at noodls] - FDA Advisory Committee to Review NUPLAZID™(Pimavanserin)New Drug Application for the Treatment of Parkinson's Disease Psychosis SAN DIEGO--(BUSINESS WIRE)--Mar. 29, 2016-- ACADIA Pharmaceuticals Inc. (NASDAQ: ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 4Q loss,2016-02-29 12:27:26 +0000,http://sg.finance.yahoo.com/news/acadia-reports-4q-loss-122726737.html,Acadia reports 4Q loss
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID™ (Pimavanserin) for the Treatment of Parkinson’s Disease Psychosis,2016-01-29 21:19:29 +0000,http://www.publicnow.com/view/36E0685F37AD68ECB7EC892039E09B52FF31A475,"[at noodls] - Advisory Committee Meeting Scheduled for --(BUSINESS WIRE)--Jan. 29, 2016-- (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals Appoints James (Randy) R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer",2016-01-25 14:27:02 +0000,http://www.publicnow.com/view/1DD77F5B950ECBFE1719B6FBD79DFE6F7F9DD304,"[at noodls] - --(BUSINESS WIRE)--Jan. 25, 2016-- (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous ..."
ACAD,ACAD:UW,BBG000BHGMW8,ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors,2016-01-11 14:18:05 +0000,http://www.noodls.com/view/55676347F8FA1CA94D7A333E0172C374C5389AE3,"[at noodls] - --(BUSINESS WIRE)--Jan. 11, 2016-- (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous ..."
ACAD,ACAD:UW,BBG000BHGMW8,"ACADIA Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on January 12, 2016",2016-01-07 14:22:02 +0000,http://www.noodls.com/view/02C7E950447D7F9CB0D72D0CBC7F28E1DEE13011,"[at noodls] - --(BUSINESS WIRE)--Jan. 7, 2016-- (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous ..."
ACAD,ACAD:UW,BBG000BHGMW8,Acadia reports 3Q loss,2015-11-05 22:19:24 +0000,http://sg.finance.yahoo.com/news/acadia-reports-3q-loss-221924446.html,Acadia reports 3Q loss
ACAD,ACAD:UW,BBG000BHGMW8,Acadia misses 3Q profit forecasts,2014-11-10 22:13:06 +0000,http://sg.finance.yahoo.com/news/acadia-misses-3q-profit-forecasts-221306689--finance.html,Acadia misses 3Q profit forecasts
